10-Q 1 iivi-10q_20180331.htm 10-Q

\

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2018

☐ | Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from to .

Commission File Number: 0-16195

II-VI INCORPORATED

(Exact name of registrant as specified in its charter)

PENNSYLVANIA |  | 25-1214948
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
375 Saxonburg Boulevard |  |
Saxonburg, PA |  | 16056
(Address of principal executive offices) |  | (Zip Code)

Registrant’s telephone number, including area code: 724-352-4455

N/A

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer | ☒ | Accelerated filer | ☐
Non-accelerated filer | ☐ | Smaller reporting company | ☐
|  | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

At May 2, 2018, 62,544,530 shares of Common Stock, no par value, of the registrant were outstanding.

II-VI INCORPORATED

INDEX

|  | Page No.
PART I - FINANCIAL INFORMATION |  |
Item 1. |  | Financial Statements: |  |
|  | Condensed Consolidated Balance Sheets – March 31, 2018 and June 30, 2017 (Unaudited) |  | 3
|  | Condensed Consolidated Statements of Earnings – Three and nine months ended March 31, 2018 and 2017 (Unaudited) |  | 4
|  | Condensed Consolidated Statements of Comprehensive Income – Three and nine months ended March 31, 2018 and 2017 (Unaudited) |  | 6
|  | Condensed Consolidated Statements of Cash Flows – Nine Months Ended March 31, 2018 and 2017 (Unaudited) |  | 7
|  | Condensed Consolidated Statement of Shareholders’ Equity – Nine Months Ended March 31, 2018 (Unaudited) |  | 8
|  | Notes to Condensed Consolidated Financial Statements (Unaudited) |  | 9
Item 2. |  | Management’s Discussion and Analysis of Financial Condition and Results of Operations |  | 26
Item 3. |  | Quantitative and Qualitative Disclosures About Market Risk |  | 35
Item 4. |  | Controls and Procedures |  | 37
PART II - OTHER INFORMATION |  |
Item 1. |  | Legal Proceedings |  | 38
Item 1A. |  | Risk Factors |  | 38
Item 2. |  | Issuer Purchases of Equity Securities |  | 38
Item 6. |  | Exhibits |  | 39

2

PART I - FINANCIAL INFORMATION

Item 1. | FINANCIAL STATEMENTS

II-VI Incorporated and Subsidiaries

Condensed Consolidated Balance Sheets (Unaudited)

($000)

|  | March 31, |  |  | June 30, |
|  | 2018 |  |  | 2017 |
Assets |  |  |  |  |  |  |  |
Current Assets |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 263,244 |  |  | $ | 271,888 |
Accounts receivable - less allowance for doubtful accounts of $1,143 at March 31, 2018 and $1,314 at June 30, 2017 |  |  | 192,766 |  |  |  | 193,379 |
Inventories |  |  | 249,548 |  |  |  | 203,695 |
Prepaid and refundable income taxes |  |  | 7,116 |  |  |  | 6,732 |
Prepaid and other current assets |  |  | 33,471 |  |  |  | 26,602 |
Total Current Assets |  |  | 746,145 |  |  |  | 702,296 |
Property, plant & equipment, net |  |  | 507,690 |  |  |  | 367,728 |
Goodwill |  |  | 274,516 |  |  |  | 250,342 |
Other intangible assets, net |  |  | 129,142 |  |  |  | 133,957 |
Investments |  |  | 68,222 |  |  |  | 11,727 |
Deferred income taxes |  |  | 2,618 |  |  |  | 3,023 |
Other assets |  |  | 8,901 |  |  |  | 8,224 |
Total Assets |  | $ | 1,737,234 |  |  | $ | 1,477,297 |
Liabilities and Shareholders' Equity |  |  |  |  |  |  |  |
Current Liabilities |  |  |  |  |  |  |  |
Current portion of long-term debt |  | $ | 20,000 |  |  | $ | 20,000 |
Accounts payable |  |  | 77,270 |  |  |  | 65,540 |
Accrued compensation and benefits |  |  | 53,856 |  |  |  | 58,178 |
Accrued income taxes payable |  |  | 18,342 |  |  |  | 12,178 |
Other accrued liabilities |  |  | 33,118 |  |  |  | 29,056 |
Total Current Liabilities |  |  | 202,586 |  |  |  | 184,952 |
Long-term debt |  |  | 430,992 |  |  |  | 322,022 |
Capital lease obligation |  |  | 22,574 |  |  |  | 23,415 |
Deferred income taxes |  |  | 27,046 |  |  |  | 15,345 |
Other liabilities |  |  | 38,864 |  |  |  | 31,000 |
Total Liabilities |  |  | 722,062 |  |  |  | 576,734 |
Shareholders' Equity |  |  |  |  |  |  |  |
Preferred stock, no par value; authorized - 5,000,000 shares; none issued |  |  | - |  |  |  | - |
Common stock, no par value; authorized - 300,000,000 shares; issued - 74,925,863 shares at March 31, 2018; 74,081,451 shares at June 30, 2017 |  |  | 346,500 |  |  |  | 269,638 |
Accumulated other comprehensive income (loss) |  |  | 17,107 |  |  |  | (13,778 | )
Retained earnings |  |  | 808,897 |  |  |  | 748,062 |
|  |  | 1,172,504 |  |  |  | 1,003,922 |
Treasury stock, at cost - 12,458,693 shares at March 31, 2018 and 10,940,062 shares at June 30, 2017 |  |  | (157,332 | ) |  |  | (103,359 | )
Total Shareholders' Equity |  |  | 1,015,172 |  |  |  | 900,563 |
Total Liabilities and Shareholders' Equity |  | $ | 1,737,234 |  |  | $ | 1,477,297 |

- See notes to condensed consolidated financial statements.

3

II-VI Incorporated and Subsidiaries

Condensed Consolidated Statements of Earnings (Unaudited)

($000 except per share data)

|  | Three Months Ended |
|  | March 31, |
|  | 2018 |  |  | 2017 |
Revenues |  | $ | 294,746 |  |  | $ | 244,987 |
Costs, Expenses and Other Expense (Income) |  |  |  |  |  |  |  |
Cost of goods sold |  |  | 176,361 |  |  |  | 147,277 |
Internal research and development |  |  | 30,560 |  |  |  | 25,380 |
Selling, general and administrative |  |  | 53,087 |  |  |  | 43,291 |
Interest expense |  |  | 5,014 |  |  |  | 1,936 |
Other expense (income), net |  |  | (1,496 | ) |  |  | (2,164 | )
Total Costs, Expenses & Other Expense (Income) |  |  | 263,526 |  |  |  | 215,720 |
Earnings Before Income Taxes |  |  | 31,220 |  |  |  | 29,267 |
Income Taxes |  |  | 1,122 |  |  |  | 6,837 |
Net Earnings |  | $ | 30,098 |  |  | $ | 22,430 |
Basic Earnings Per Share |  | $ | 0.48 |  |  | $ | 0.36 |
Diluted Earnings Per Share |  | $ | 0.45 |  |  | $ | 0.35 |

- See notes to condensed consolidated financial statements.

4

II-VI Incorporated and Subsidiaries

Condensed Consolidated Statements of Earnings (Unaudited)

($000 except per share data)

|  | Nine Months Ended |
|  | March 31, |
|  | 2018 |  |  | 2017 |
Revenues |  | $ | 837,719 |  |  | $ | 698,329 |
Costs, Expenses and Other Expense (Income) |  |  |  |  |  |  |  |
Cost of goods sold |  |  | 503,926 |  |  |  | 418,754 |
Internal research and development |  |  | 83,898 |  |  |  | 70,844 |
Selling, general and administrative |  |  | 152,833 |  |  |  | 128,865 |
Interest expense |  |  | 13,303 |  |  |  | 4,547 |
Other expense (income), net |  |  | (4,228 | ) |  |  | (9,611 | )
Total Costs, Expenses & Other Expense (Income) |  |  | 749,732 |  |  |  | 613,399 |
Earnings Before Income Taxes |  |  | 87,987 |  |  |  | 84,930 |
Income Taxes |  |  | 27,152 |  |  |  | 22,303 |
Net Earnings |  | $ | 60,835 |  |  | $ | 62,627 |
Basic Earnings Per Share |  | $ | 0.97 |  |  | $ | 1.00 |
Diluted Earnings Per Share |  | $ | 0.93 |  |  | $ | 0.97 |

- See notes to condensed consolidated financial statements.

5

II-VI Incorporated and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (Unaudited)

($000)

|  | Three Months Ended |  |  | Nine Months Ended |
|  | March 31, |  |  | March 31, |
|  | 2018 |  |  | 2017 |  |  | 2018 |  |  | 2017 |
Net earnings |  | $ | 30,098 |  |  | $ | 22,430 |  |  | $ | 60,835 |  |  | $ | 62,627 |
Other comprehensive income (loss): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustments |  |  | 15,703 |  |  |  | 3,002 |  |  |  | 30,885 |  |  |  | (12,145 | )
Amortization of net actuarial gains and losses, net of taxes of ($32) and $0 for the three and nine months ended March 31, 2018, respectively, and ($40) and $45 for the three and nine months ended March 31, 2017, respectively |  |  | (118 | ) |  |  | (149 | ) |  |  | - |  |  |  | 163 |
Comprehensive income |  | $ | 45,683 |  |  | $ | 25,283 |  |  | $ | 91,720 |  |  | $ | 50,645 |

- See notes to condensed consolidated financial statements.

6

II-VI Incorporated and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Unaudited)

($000)

|  | Nine Months Ended |
|  | March 31, |
|  | 2018 |  |  | 2017 |
Cash Flows from Operating Activities |  |  |  |  |  |  |  |
Net earnings |  | $ | 60,835 |  |  | $ | 62,627 |
Adjustments to reconcile net earnings to net cash provided by operating activities: |  |  |  |  |  |  |  |
Depreciation |  |  | 47,157 |  |  |  | 35,190 |
Amortization |  |  | 10,992 |  |  |  | 9,532 |
Share-based compensation expense |  |  | 11,562 |  |  |  | 8,695 |
Losses (gains) on foreign currency remeasurements and transactions |  |  | 789 |  |  |  | (3,633 | )
Earnings from equity investments |  |  | (2,607 | ) |  |  | (654 | )
Deferred income taxes |  |  | (1,612 | ) |  |  | 248 |
Increase (decrease) in cash from changes in (net of effect of acquisitions): |  |  |  |  |  |  |  |
Accounts receivable |  |  | 5,644 |  |  |  | (8,220 | )
Inventories |  |  | (33,446 | ) |  |  | (20,273 | )
Accounts payable |  |  | 12,205 |  |  |  | 7,610 |
Income taxes |  |  | 9,558 |  |  |  | 2,958 |
Accrued compensation and benefits |  |  | (6,039 | ) |  |  | (12,387 | )
Other operating net assets |  |  | (1,093 | ) |  |  | (3,321 | )
Net cash provided by operating activities |  |  | 113,945 |  |  |  | 78,372 |
Cash Flows from Investing Activities |  |  |  |  |  |  |  |
Additions to property, plant & equipment |  |  | (116,477 | ) |  |  | (99,135 | )
Purchases of businesses |  |  | (80,503 | ) |  |  | (580 | )
Purchase of equity investment |  |  | (51,655 | ) |  |  | - |
Other investing activities |  |  | 429 |  |  |  | 1,707 |
Net cash used in investing activities |  |  | (248,206 | ) |  |  | (98,008 | )
Cash Flows from Financing Activities |  |  |  |  |  |  |  |
Proceeds from issuance of 0.25% convertible senior notes due 2022 |  |  | 345,000 |  |  |  | - |
Proceeds from borrowings under Credit Facility |  |  | 100,000 |  |  |  | 64,000 |
Payments on borrowings under Credit Facility |  |  | (277,000 | ) |  |  | (20,000 | )
Purchases of treasury stock |  |  | (49,875 | ) |  |  | - |
Proceeds from exercises of stock options |  |  | 8,836 |  |  |  | 14,625 |
Payments in satisfaction of employees' minimum tax obligations |  |  | (4,040 | ) |  |  | (3,407 | )
Debt issuance costs |  |  | (10,061 | ) |  |  | (1,384 | )
Net cash provided by financing activities |  |  | 112,860 |  |  |  | 53,834 |
Effect of exchange rate changes on cash and cash equivalents |  |  | 12,757 |  |  |  | (5,062 | )
Net (decrease) increase in cash and cash equivalents |  |  | (8,644 | ) |  |  | 29,136 |
Cash and Cash Equivalents at Beginning of Period |  |  | 271,888 |  |  |  | 218,445 |
Cash and Cash Equivalents at End of Period |  | $ | 263,244 |  |  | $ | 247,581 |
Cash paid for interest |  | $ | 4,680 |  |  | $ | 3,937 |
Cash paid for income taxes |  | $ | 16,588 |  |  | $ | 16,852 |
Non-cash transactions: |  |  |  |  |  |  |  |
Capital lease obligation incurred on facility lease |  | $ | - |  |  | $ | 25,000 |
Additions to property, plant & equipment included in accounts payable |  | $ | 3,388 |  |  | $ | 6,521 |

- See notes to condensed consolidated financial statements.

7

e II-VI Incorporated and Subsidiaries

Condensed Consolidated Statement of Shareholders’ Equity (Unaudited)

(000)

|  |  |  |  |  |  |  |  |  | Accumulated |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | Other |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Common Stock |  |  | Comprehensive |  |  | Retained |  |  | Treasury Stock |  |  |  |  |
|  | Shares |  |  | Amount |  |  | Income (Loss) |  |  | Earnings |  |  | Shares |  |  | Amount |  |  | Total |
Balance - June 30, 2017 |  |  | 74,081 |  |  | $ | 269,638 |  |  | $ | (13,778 | ) |  | $ | 748,062 |  |  |  | (10,940 | ) |  | $ | (103,359 | ) |  | $ | 900,563 |
Shares issued under share-based compensation plans |  |  | 845 |  |  |  | 8,836 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 8,836 |
Shares acquired in satisfaction of minimum tax withholding obligations |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (109 | ) |  |  | (4,040 | ) |  |  | (4,040 | )
Net earnings |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 60,835 |  |  |  | - |  |  |  | - |  |  |  | 60,835 |
Purchases of treasury stock |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (1,415 | ) |  |  | (49,875 | ) |  |  | (49,875 | )
Treasury stock under deferred compensation arrangements |  |  | - |  |  |  | 58 |  |  |  | - |  |  |  | - |  |  |  | 5 |  |  |  | (58 | ) |  |  | - |
Foreign currency translation adjustments |  |  | - |  |  |  | - |  |  |  | 30,885 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 30,885 |
Equity portion of convertible debt, net of issuance costs of $1,694 |  |  | - |  |  |  | 56,406 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 56,406 |
Share-based compensation expense |  |  | - |  |  |  | 11,562 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 11,562 |
Balance - March 31, 2018 |  |  | 74,926 |  |  | $ | 346,500 |  |  | $ | 17,107 |  |  | $ | 808,897 |  |  |  | (12,459 | ) |  | $ | (157,332 | ) |  | $ | 1,015,172 |

- See notes to condensed consolidated financial statements.

8

II-VI Incorporated and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1. | Basis of Presentation

The condensed consolidated financial statements of II-VI Incorporated (“II-VI”, the “Company”, “we”, “us” or “our”) for the three and nine months ended March 31, 2018 and 2017 are unaudited. In the opinion of management, all adjustments considered necessary for a fair presentation for the periods presented have been included. All adjustments are of a normal recurring nature unless disclosed otherwise. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2017. The consolidated results of operations for the three and nine months ended March 31, 2018 are not necessarily indicative of the results to be expected for the full fiscal year. The June 30, 2017 Condensed Consolidated Balance Sheet information was derived from the Company’s audited financial statements.

Note 2. | Recently Issued Financial Accounting Standards

Adopted Pronouncements

In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting. ASU 2017-09 provides clarification on when modification accounting should be used for changes to the terms or conditions of a share-based payment award. This ASU does not change the accounting for modifications but clarifies that modification accounting guidance should only be applied if there is a change to the value, vesting conditions, or award classification and would not be required if the changes are considered non-substantive. The new guidance is applied prospectively to awards modified on or after the adoption date. The adoption of this standard did not have a material effect on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Accounting for Goodwill Impairment. This standard removes the second step of the goodwill impairment test, where a determination of the fair value of individual assets and liabilities of a reporting unit were needed to measure the goodwill impairment. Under this updated standard, goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The Company has adopted this standard for any impairment test that is performed after July 1, 2017 as permitted under the standard.

In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. This update simplifies several aspects of the accounting for employee share-based payment transactions, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, and classification in the statement of cash flows. Under this ASU, excess tax benefits or deficiencies are recognized in income tax expense in the Condensed Consolidated Statement of Earnings. Upon adoption of this ASU, the Company had a valuation allowance for its U.S. deferred tax assets and did not recognize any tax benefit. Had the Company not had a valuation allowance, the Company would have recognized a tax benefit of $2.4 million. The impact to the Company’s dilutive shares under this new standard was immaterial.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities (Topic 825). This update requires that public entities measure equity investments with readily determinable fair values, at fair value, with changes in their fair value recorded through net income. This ASU also clarifies that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available for sale securities in combination with the entity’s other deferred tax assets. The adoption of this standard did not have a material effect on the Company’s Consolidated Financial Statements.

In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. This update simplifies the measurement of inventory valuation at the lower of cost or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The adoption of this standard did not have a material effect on the Company’s Consolidated Financial Statements.

In March 2016, the FASB issued ASU 2016-07, Investments – Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting. This update eliminates the requirement to retrospectively apply the equity method in previous periods when an investor obtains significant influence over an investee. The adoption of this standard did not have a material effect on the Company’s Consolidated Financial Statements.

9

Revenue Recognition Pronouncement Currently Under Evaluation

In May 2014, the FASB issued ASU 2014-09: Revenue from Contracts with Customers (Topic 606) which supersedes virtually all existing revenue recognition guidance under U.S. GAAP. The ASU's core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The update allows for the use of either the retrospective or modified retrospective approach of adoption. The update will be effective for the Company’s 2019 fiscal year (July 1, 2018).

We continued our evaluation of the impact of the ASU in fiscal 2018 by evaluating its impact on selected contracts at each of our business units. As the ASU will supersede all existing revenue guidance affecting U.S. GAAP, it could impact revenue and cost recognition on our contracts across all our business units, as well as our business processes and our information technology. As a result, our evaluation of the effect of the ASU will continue through the end of fiscal year 2018. The Company has assessed its military related contracts that comprise approximately 10% of consolidated revenues. Under the ASU, based on the preliminary assessment, the Company will accelerate the recognition of revenues for certain contracts as the customer obtains control of the goods or service promised in the contract. The Company is currently evaluating the commercial portion of its business; the assessment will be completed during fiscal year 2018. Based upon our evaluation to date, we cannot currently estimate the impacts of adopting the ASU at this time. The Company will adopt this ASU using the modified retrospective method whereby the cumulative effect of applying the ASU will be recognized at the beginning of the year of adoption.

Other Pronouncements Currently Under Evaluation

In February 2018, the FASB issued ASU 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The guidance permits an entity to reclassify tax effects stranded in accumulated other comprehensive income as a result of tax reform to retained earnings. The standard will be effective for the Company’s 2020 fiscal year. Early adoption is permitted. The Company is evaluating the impact of this guidance on the Company’s Consolidated Financial Statements.

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities. The guidance eliminates the requirement to separately measure and report hedge ineffectiveness and generally requires the entire change in the fair value of a hedging instrument to be presented in the same income statement line as the hedged item. The standard will be effective for the Company’s 2019 fiscal year. The adoption of this ASU is not expected to have a material effect on the Company’s Consolidated Financial Statements.

In March 2017, the FASB issued ASU 2017-07, Compensation (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. This update affects employers’ presentation of defined benefit retirement plan costs. Early adoption is permitted. The standard will be effective for the Company’s 2019 fiscal year. The adoption of this ASU is not expected to have a material effect on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. This update changes the definition of a business to assist entities with evaluating when a set of transferred assets and activities is a business. Early adoption is permitted. The standard will be effective for the Company’s 2019 fiscal year. The adoption of this ASU is not expected to have a material effect on the Company’s Consolidated Financial Statements.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. This update requires that when intra-entity asset transfers occur, the entity must recognize tax effects in the period in which the transfer occurs. The standard will be effective for the Company’s 2019 fiscal year. Early adoption is permitted. The adoption of this ASU is not expected to have a material effect on the Company’s Consolidated Financial Statements.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The guidance clarifies how entities should classify certain cash receipts and cash payments on the statement of cash flows. The guidance also clarifies how the predominance principle should be applied when cash receipts and cash payments have aspects of more than one class of cash flow. The update will be effective for the Company’s 2019 fiscal year. Early adoption is permitted. The Company is evaluating the impact of this guidance on the Company’s Consolidated Financial Statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This update is intended to provide financial statement users with more decision-useful information about expected credit losses and other commitments to extend credit held by the reporting entity. The standard replaces the incurred loss impairment methodology in current GAAP with one that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The update will be effective for the Company’s 2021 fiscal

10

year. Early adoption is permitted. The Company is evaluating the impact of this guidance on the Company’s Consolidate d Financial Statements.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). This update requires that a lessee recognize leased assets with terms greater than 12 months on the balance sheet for the rights and obligations created by those leases. The standard will be effective for the Company’s 2020 fiscal year. Early adoption is permitted. The Company is evaluating the impact of this guidance on the Company’s Consolidated Financial Statements.

Note 3. | Acquisitions and Investment

CoAdna, Inc.

In March 2018, the Company announced its intention to acquire CoAdna, Inc.(“CoAdna”), a publically traded company on the Taiwan Stock Exchange and based in Sunnyvale, CA, in a cash transaction valued at approximately $85.0 million net of any cash acquired. The transaction is expected to close during the first quarter of fiscal year 2019 and is subject to the approval of CoAdna’s shareholders, regulatory approvals and customary closing conditions.

Purchase of Equity Investment

In November 2017, the Company acquired a 93.8% equity investment in a privately-held company for $51.5 million. In addition, during the quarter ended March 31, 2018, the Company paid $0.2 million for a working capital adjustment to that purchase price. The Company’s pro-rata share of earnings from this investment since the acquisition date was $0.8 million and $2.0 million, for the three and nine months ended March 31, 2018, respectively, and was recorded in other expense (income), net in the Condensed Consolidated Statements of Earnings.

This nonconsolidated investment is accounted for under the equity method of accounting (“Equity Investment”). The following table summarizes the Company's equity in the nonconsolidated investment:

|  | Interest |  | Ownership % as of |  |  | Equity as of
Location |  | Type |  | March 31, 2018 |  |  | March 31, 2018 ($000)
USA |  | Equity Investment |  | 93.80% |  |  | $ |  | 55,841 |  |

The Equity Investment has been determined to be a variable interest entity because the Company has an overall 93.8% economic position in the investee comprising a significant portion of its capitalization, but has only a 25% voting interest. The Company’s obligation to receive rewards and absorb expected losses is disproportionate to its voting interest. The Company is not the primary beneficiary because it does not have the power to direct the activities of the equity investment that most significantly impact its economic performance. Certain business decisions, including, but not limited to, decisions with respect to operating budgets, material capital expenditures, indebtedness, significant acquisitions or dispositions, and strategic decisions, require the approval of owners holding a majority percentage in the Equity Investment. Beginning on the date it was acquired, the Company accounted for its interest as an equity method investment as the Company has the ability to exercise significant influence over operating and financial policies of the Equity Investment.

As of March 31, 2018, the Company’s maximum financial statement exposure related to the Equity Investment was approximately $55.8 million, which is included in the investments balance on the Condensed Consolidated Balance Sheet as of March 31, 2018.

The Company has the right to purchase all of the outstanding interest of each of the minority equity holders and the minority equity holders have the right to cause the Company to purchase all of their outstanding interests at any time on or after the third anniversary of the investment or earlier upon certain events. The purchase price is equal to the greater of: (a) (i) the product of the aggregate trailing 12-month revenues of the investment preceding the date of purchase, multiplied by (ii) a factor of 2.9 multiplied by (iii) a factor of 0.723, multiplied by (iv) the percentage interest owned by each minority equity holder and (b) $966,666. The Company performed a Monte Carlo simulation to estimate the fair value of the net put option at the investment date and recorded a liability of $2.2 million in other long-term liabilities in the Condensed Consolidated Balance Sheet at the acquisition date in accordance with ASC 815-10, Derivatives and Hedging. The fair value of the net put option is adjusted as necessary on a quarterly basis with any changes in the fair value recorded through earnings. The change in fair value of the net purchase option from the investment date to March 31, 2018 was not material.

11

Kaiam Laser Limited, Inc.

In August 2017, the Company acquired Kaiam Laser Limited, Inc. (“Kaiam”), a privately held company based in Newton Aycliffe, United Kingdom. Under the terms of the merger agreement, the consideration consisted of cash paid at the acquisition date of $79.5 million, net of cash acquired and an adjustment for a purchase price reduction recorded during the quarter ended March 31, 2018 of $0.5 million. The acquisition of Kaiam provides the Company with a 150mm wafer fabrication platform to significantly expand the Company’s capacity for the production of vertical cavity surface emitting lasers (“VCSELs”) for the 3D sensing market and broadens the capability to address new market opportunities in other compound semiconductor materials. Kaiam now operates under the name II-VI Compound Semiconductor Ltd. within the Company’s II-VI Laser Solutions operating segment. Due to the timing of the acquisition, the Company is still in the process of measuring the fair value of assets acquired, including tangible, intangible assets and related deferred income taxes.

The following table presents the preliminary allocation of the purchase price of the assets acquired and liabilities assumed at the date of acquisition, as the Company intends to finalize its accounting for the acquisition of II-VI Compound Semiconductor Ltd. within one year from the date of acquisition ($000):

Assets |  |  |  |
Accounts receivable |  | $ | 79 |
Inventories |  |  | 4,559 |
Prepaid and other assets |  |  | 1,246 |
Property, plant & equipment |  |  | 63,899 |
Intangible assets |  |  | 4,046 |
Goodwill |  |  | 19,198 |
Total assets acquired |  | $ | 93,027 |
Liabilities |  |  |  |
Accounts payable |  | $ | 751 |
Other accrued liabilities |  |  | 2,486 |
Deferred tax liabilities |  |  | 10,797 |
Total liabilities assumed |  |  | 14,034 |
Net assets acquired |  | $ | 78,993 |

The goodwill of $19.2 million is included in the II-VI Laser Solutions segment and is attributed to the expected synergies and the assembled workforce of II-VI Compound Semiconductor Ltd. None of the goodwill is deductible for income tax purposes. The Company expensed transaction costs of $0.6 million for the nine months ended March 31, 2018.

The amount of revenues of II-VI Compound Semiconductor Ltd. included in the Company’s Consolidated Statements of Earnings for the three and nine months ended March 31, 2018 was $0.9 million and $2.5 million, respectively. The amount of net losses of II-VI Compound Semiconductor Ltd. included in the Company’s Condensed Consolidated Statements of Earnings for the three and nine months ended March 31, 2018 was $4.5 million and $10.7 million, respectively.

Integrated Photonics, Inc.

In June 2017, the Company acquired Integrated Photonics, Inc. (“IPI”), a privately held company based in New Jersey. IPI is a leader in engineered magneto-optic materials that enable high-performance directional components such as optical isolators for the optical communications market. Under the terms of the merger agreement, the consideration consisted of initial cash paid at the acquisition date of $40.1 million, net of cash acquired and a final working capital adjustment of $0.8 million. In addition, the agreement provides up to a maximum of $2.5 million of additional cash earnout opportunities based upon IPI achieving certain agreed upon financial and transitional objectives, which if earned would be payable in the amount of $2.5 million for the achievement of the annual target.

The following table presents the preliminary purchase price at the date of acquisition ($000):

Net cash paid at acquisition |  | $ | 40,098 |
Working capital adjustment |  |  | 848 |
Fair value of cash earnout arrangement |  |  | 2,215 |
Purchase price |  | $ | 43,161 |

12

The following table presents the preliminary allocation of the purchase price of the assets acquired and liabilities assumed at the date of acquisition, as the Company intends to finalize its accounting for the valuation of property, plant and equipment, identifiable intangibles and deferred income tax liabilities and anticipates completion of the valuation within one year from the date of the acquisition ($000):

Assets |  |  |  |
Accounts receivable |  | $ | 2,083 |
Inventories |  |  | 3,968 |
Prepaid and other assets |  | 322 |
Property, plant & equipment |  |  | 11,235 |
Intangible assets |  |  | 23,554 |
Goodwill |  |  | 17,514 |
Total assets acquired |  | $ | 58,676 |
Liabilities |  |  |  |
Accounts payable |  | $ | 847 |
Other accrued liabilities |  |  | 1,032 |
Long-term debt assumed |  |  | 3,834 |
Deferred tax liabilities |  |  | 9,802 |
Total liabilities assumed |  |  | 15,515 |
Net assets acquired |  | $ | 43,161 |

The goodwill of $17.5 million is included in the II-VI Photonics segment and is attributed to the expected synergies and the assembled workforce of IPI. None of the goodwill is deductible for income tax purposes. The fair value of accounts receivable acquired was $2.1 million with the gross contractual amount being $2.1 million. At the time of acquisition, the Company expected to collect all of the accounts receivable. The Company expensed transaction costs of $0.3 million all within the year ended June 30, 2017.

The amount of revenues of IPI included in the Company’s Condensed Consolidated Statements of Earnings for the three and nine months ended March 31, 2018 was $4.9 million and $15.2 million, respectively. The amount of net earnings of IPI included in the Company’s Consolidated Statements of Earnings for the three and nine months ended March 31, 2018 was $1.1 million and $2.5 million, respectively.

Note 4. | Inventories

The components of inventories were as follows ($000):

|  | March 31, |  |  | June 30, |
|  | 2018 |  |  | 2017 |
Raw materials |  | $ | 90,752 |  |  | $ | 78,979 |
Work in progress |  |  | 93,614 |  |  |  | 61,679 |
Finished goods |  |  | 65,182 |  |  |  | 63,037 |
|  | $ | 249,548 |  |  | $ | 203,695 |

13

Note 5. | Property, Plant and Equipment

Property, plant and equipment consists of the following ($000):

|  | March 31, |  |  | June 30, |
|  | 2018 |  |  | 2017 |
Land and improvements |  | $ | 9,445 |  |  | $ | 5,667 |
Buildings and improvements |  |  | 217,300 |  |  |  | 144,293 |
Machinery and equipment |  |  | 598,108 |  |  |  | 492,042 |
Construction in progress |  |  | 91,184 |  |  |  | 88,458 |
|  |  | 916,037 |  |  |  | 730,460 |
Less accumulated depreciation |  |  | (408,347 | ) |  |  | (362,732 | )
|  | $ | 507,690 |  |  | $ | 367,728 |

Note 6. | Goodwill and Other Intangible Assets

Changes in the carrying amount of goodwill were as follows ($000):

|  | Nine Months Ended March 31, 2018 |
|  | II-VI Laser |  |  | II-VI |  |  | II-VI Performance |  |  |  |  |
|  | Solutions |  |  | Photonics |  |  | Products |  |  | Total |
Balance-beginning of period |  | $ | 84,180 |  |  | $ | 113,272 |  |  | $ | 52,890 |  |  | $ | 250,342 |
Goodwill acquired |  |  | 19,198 |  |  |  | - |  |  |  | - |  |  |  | 19,198 |
Goodwill adjustment for prior year acquisition - IPI |  |  | - |  |  |  | 407 |  |  |  | - |  |  |  | 407 |
Foreign currency translation |  |  | 2,235 |  |  |  | 2,334 |  |  |  | - |  |  |  | 4,569 |
Balance-end of period |  | $ | 105,613 |  |  | $ | 116,013 |  |  | $ | 52,890 |  |  | $ | 274,516 |

The gross carrying amount and accumulated amortization of the Company’s intangible assets other than goodwill as of March 31, 2018 and June 30, 2017 were as follows ($000):

|  | March 31, 2018 |  |  | June 30, 2017 |
|  | Gross |  |  |  |  |  |  | Net |  |  | Gross |  |  |  |  |  |  | Net |
|  | Carrying |  |  | Accumulated |  |  | Book |  |  | Carrying |  |  | Accumulated |  |  | Book |
|  | Amount |  |  | Amortization |  |  | Value |  |  | Amount |  |  | Amortization |  |  | Value |
Technology and Patents |  | $ | 67,339 |  |  | $ | (32,349 | ) |  | $ | 34,990 |  |  | $ | 65,438 |  |  | $ | (27,313 | ) |  | $ | 38,125 |
Trademarks |  |  | 16,051 |  |  |  | (1,438 | ) |  |  | 14,613 |  |  |  | 15,806 |  |  |  | (1,340 | ) |  |  | 14,466 |
Customer Lists |  |  | 128,399 |  |  |  | (48,882 | ) |  |  | 79,517 |  |  |  | 123,058 |  |  |  | (41,740 | ) |  |  | 81,318 |
Other |  |  | 1,579 |  |  |  | (1,557 | ) |  |  | 22 |  |  |  | 1,571 |  |  |  | (1,523 | ) |  |  | 48 |
Total |  | $ | 213,368 |  |  | $ | (84,226 | ) |  | $ | 129,142 |  |  | $ | 205,873 |  |  | $ | (71,916 | ) |  | $ | 133,957 |

Amortization expense recorded on the Company’s intangible assets was $3.6 million and $11.0 million for the three and nine months ended March 31, 2018, respectively, and was $3.1 million and $9.5 million for the three and nine months ended March 31, 2017, respectively.

In conjunction with the acquisition of II-VI Compound Semiconductors Ltd., the Company recorded $0.4 million attributed to the value of technology and patents and $3.6 million of customer lists. The intangibles were recorded based on the Company’s preliminary purchase price allocation utilizing either a discounted cash flow or relief from royalty method to derive the fair value. The valuation is expected to be finalized within one year from the date of acquisition.

14

Technology and patents are being amortized over a range of 60 to 240 months, with a weighted av erage remaining life of approximately 93 months. Customer lists are being amortized over a range of approximately 120 to 240 months with a weighted average remaining life of approximately 142 months. The gross carrying amount of trademarks includes $14.3 m illion of acquired trade names with indefinite lives that are not amortized but tested annually for impairment or more frequently if a triggering event occurs. Included in the gross carrying amount and accumulated amortization of the Company’s intangible a ssets is the effect of foreign currency translation on that portion of the intangible assets relating to the Company’s German, U.K. and Chinese subsidiaries.

At March 31, 2018, the estimated amortization expense for the existing intangible assets for each of the five succeeding fiscal years is as follows ($000):

Fiscal Year Ending June 30, |  | Amount |
Remaining 2018 |  | $ | 3,500 |
2019 |  |  | 14,000 |
2020 |  |  | 13,000 |
2021 |  |  | 12,300 |
2022 |  |  | 10,900 |

Note 7. | Debt

The components of debt for the periods indicated were as follows ($000):

| March 31, |  |  | June 30, |
| 2018 |  |  | 2017 |
0.25% Convertible senior notes | $ | 345,000 |  |  | $ | - |
Convertible senior notes unamortized discount attributable to cash conversion option and debt issuance costs including initial purchaser discount |  | (59,450 | ) |  |  | - |
Term loan, interest at LIBOR, as defined, plus 1.75% and 1.50%, respectively |  | 70,000 |  |  |  | 85,000 |
Line of credit, interest at LIBOR, as defined, plus 1.75% and 1.50%, respectively |  | 90,000 |  |  |  | 252,000 |
Credit facility unamortized debt issuance costs |  | (1,217 | ) |  |  | (1,491 | )
Yen denominated line of credit, interest at LIBOR, as defined, plus 1.75% |  | 2,825 |  |  |  | 2,679 |
Note payable assumed in IPI acquisition |  | 3,834 |  |  |  | 3,834 |
Total debt |  | 450,992 |  |  |  | 342,022 |
Current portion of long-term debt |  | (20,000 | ) |  |  | (20,000 | )
Long-term debt, less current portion | $ | 430,992 |  |  | $ | 322,022 |

0.25% Convertible Senior Notes

On August 24, 2017, the Company entered into a purchase agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representative of the several initial purchasers named therein (collectively, the “Initial Purchasers”), to issue and sell $300 million aggregate principal amount of our 0.25% convertible senior notes due 2022 (the "Notes") in a private placement to qualified institutional buyers within the meaning of Rule 144A under the Securities Act of 1933, as amended. In addition, we granted the Initial Purchasers a 30-day option to purchase up to an additional $45 million aggregate principal amount of the Notes (the “Over-Allotment Option”).

On August 29, 2017, the Initial Purchasers exercised their Over-Allotment Option to purchase the entire $45 million in aggregate principal amount of additional Notes. The Notes mature on September 1, 2022, unless earlier repurchased by the Company or converted by holders in accordance with the terms of the Notes. Interest is payable semi-annually in arrears on March 1 and September 1 of each year, beginning on March 1, 2018.

The sale of the Notes to the Initial Purchasers settled on August 29, 2017, and resulted in approximately $336 million in net proceeds to the Company after deducting the initial purchasers’ discount and the estimated offering expenses. The net proceeds from the offering and sale of the Notes were used, in part, to repurchase approximately $49.9 million of our Common Stock. The Company used the remaining net proceeds to repay $252 million on its revolving credit facility and to pay debt issuance costs of $10.1 million.

15

The Notes are governed by an Indenture between the Company, as issuer, and U.S. Bank, National Association, as trustee. The Notes are our senior unsecured obligations and ra nk senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Notes; equal in right of payment to any of our indebtedness that is not so subordinated; effectively junior in right of payment to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of our subsidiaries. In the event of our bankruptcy, liquidation, reorga nization or other winding up, our assets that secure secured debt will be available to pay obligations on the Notes only after all indebtedness under such secured debt has been repaid in full from such assets. Upon conversion, the Company will pay or deliv er, as the case may be, cash, shares of our Common Stock or a combination of cash and shares of our Common Stock, at the Company’s election.

As a result of our cash conversion option, the Company separately accounted for the value of the embedded conversion option as a debt discount. The value of the embedded conversion option was determined based on the estimated fair value of the debt without the conversion feature, which was determined using an expected present value technique (income approach) to estimate the fair value of similar nonconvertible debt; the debt discount is being amortized as additional non-cash interest expense over the term of the Notes using the effective interest method with an effective interest rate of 4.5% per annum.

The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The initial conversion rate is 21.25 shares of Common Stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of $47.06 per share of Common Stock. Throughout the term of the Notes, the conversion rate may be adjusted upon the occurrence of certain events.

Holders of the Notes will not receive any cash payment representing accrued and unpaid interest upon conversion of a note. Accrued but unpaid interest will be deemed to be paid in full upon conversion rather than cancelled, extinguished or forfeited.

Prior to the close of business on the business day immediately preceding June 1, 2022, the Notes will be convertible only upon satisfaction of at least one of the conditions as follows:

| a) | During any fiscal quarter (and only during such fiscal quarter), if the last reported sale price of our Common Stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

| b) | During the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our Common Stock and the conversion rate on each such trading day; or

| c) | Upon the occurrence of specified corporate events.

On or after June 1, 2022 until the close of business on the business day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.

As of March 31, 2018, the Notes are not yet convertible. The Notes will become convertible upon the satisfaction of at least one of the above conditions. In accounting for the transaction costs related to the Note issuance, the Company allocated the total amount of offering costs incurred to the debt and equity components based on their relative values. Offering costs attributable to the debt component, totaling $8.4 million, are being amortized as non-cash interest expense over the term of the Notes, and offering costs attributable to the equity component, totaling $1.7 million, were recorded within Shareholders' equity.

The following table sets forth total interest expense recognized related to the Notes for the three and nine months ended March 31, 2018:

| Three Months Ended March 31, 2018 |  |  | Nine Months Ended March 31, 2018 |
0.25% contractual coupon | $ | 216 |  |  | $ | 513 |
Amortization of debt discount and debt issuance costs including initial purchaser discount |  | 2,974 |  |  |  | 7,017 |
Interest expense | $ | 3,190 |  |  | $ | 7,530 |

16

Amended Credit Facility

On July 28, 2016, the Company amended and restated its existing credit agreement. The Third Amended and Restated Credit Agreement (the “Amended Credit Facility”) provides for a revolving credit facility of $325 million, as well as a $100 million term loan. The term loan is being repaid in consecutive quarterly principal payments on the first business day of each January, April, July and October, with the first payment having commenced on October 1, 2016, as follows: (i) twenty consecutive quarterly installments of $5 million and (ii) a final installment of all remaining principal due and payable on the maturity date of July 27, 2021. Amounts borrowed under the revolving credit facility are due and payable on the maturity date. The Amended Credit Facility is unsecured, but is guaranteed by each existing and subsequently acquired or organized wholly-owned domestic subsidiary of the Company. The Company has the option to request an increase to the size of the revolving credit facility in an aggregate additional amount not to exceed $100 million. The Amended Credit Facility has a five-year term through July 27, 2021 and has an interest rate of either a Base Rate Option or a Euro-Rate Option, plus an Applicable Margin, as defined in the agreement governing the Amended Credit Facility. If the Base Rate option is selected for a borrowing, the Applicable Margin is 0.00% to 1.25% and if the Euro-Rate Option is selected for a borrowing, the Applicable Margin is 1.00% to 2.25%. The Applicable Margin is based on the ratio of the Company’s consolidated indebtedness to consolidated EBITDA. Additionally, the Credit Facility is subject to certain covenants, including those relating to minimum interest coverage and maximum leverage ratios. As of March 31, 2018, the Company was in compliance with all financial covenants under its Amended Credit Facility.

Yen Loan

The Company’s Yen denominated line of credit is a 500 million Yen (approximately $4.7 million) facility. The Yen line of credit matures in August 2020. The interest rate is equal to LIBOR, as defined in the loan agreement, plus 0.625% to 1.75%. At March 31, 2018 and June 30, 2017, the Company had 300 million Yen borrowed. Additionally, the facility is subject to certain covenants, including those relating to minimum interest coverage and maximum leverage ratios. As of March 31, 2018, the Company was in compliance with all financial covenants under its Yen facility.

Note Payable

In conjunction with the acquisition of IPI, the Company assumed a non-interest bearing note payable owed to a major customer of IPI. The agreement if not terminated early by either party is payable in full in May 2019.

Aggregate Availability

The Company had aggregate availability of $236.4 million and $73.5 million under its lines of credit as of March 31, 2018 and June 30, 2017, respectively. The amounts available under the Company’s lines of credit are reduced by outstanding letters of credit. The total outstanding letters of credit supported by these credit facilities were $0.4 million and $1.2 million as of March 31, 2018 and June 30, 2017, respectively.

Weighted Average Interest Rate

The weighted average interest rate of total borrowings was 1.4% and 2.3% for the nine months ended March 31, 2018 and 2017, respectively.

Remaining Annual Principal Payments

Remaining annual principal payments under the Company’s existing credit obligations from March 31, 2018 were as follows:

|  |  |  |  |  |  |  |  |  | U.S. |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | Dollar |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Term |  |  | Yen Line |  |  | Line of |  |  | Note |  |  | Convertible |  |  |  |  |
Period |  | Loan |  |  | of Credit |  |  | Credit |  |  | Payable |  |  | Notes |  |  | Total |
Year 1 |  | $ | 20,000 |  |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | 20,000 |
Year 2 |  |  | 20,000 |  |  |  | - |  |  |  | - |  |  |  | 3,834 |  |  |  | - |  |  |  | 23,834 |
Year 3 |  |  | 20,000 |  |  |  | 2,825 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 22,825 |
Year 4 |  |  | 10,000 |  |  |  | - |  |  |  | 90,000 |  |  |  | - |  |  |  | - |  |  |  | 100,000 |
Year 5 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 345,000 |  |  |  | 345,000 |
Total |  | $ | 70,000 |  |  | $ | 2,825 |  |  | $ | 90,000 |  |  | $ | 3,834 |  |  | $ | 345,000 |  |  | $ | 511,659 |

17

Note 8. | Income Taxes

The Company’s year-to-date effective income tax rate at March 31, 2018 and 2017 was 30.9% and 26.3%, respectively. The variations between the Company’s effective tax rate and the U.S. statutory blended rate of 28% for our fiscal year ending June 30, 2018 were primarily due to the impact of the U.S. enacted tax legislation and earnings generated from the Company’s foreign operations, which are subject to income taxes at lower statutory rates.

U.S. GAAP prescribes the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements which includes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As of March 31, 2018 and June 30, 2017, the Company’s gross unrecognized income tax benefit was $8.9 million and $7.6 million, respectively. The Company has classified the uncertain tax positions as noncurrent income tax liabilities, as the amounts are not expected to be paid within one year. If recognized, $5.8 million of the gross unrecognized tax benefits at March 31, 2018 would impact the effective tax rate. The Company recognizes interest and penalties related to uncertain tax positions in the income tax provision on the Condensed Consolidated Statements of Earnings. The amount of accrued interest and penalties included in the gross unrecognized income tax benefit was $0.5 million and $0.3 million, at March 31, 2018 and June 30, 2017, respectively. Fiscal years 2014 to 2018 remain open to examination by the United States Internal Revenue Service, fiscal years 2012 to 2018 remain open to examination by certain state jurisdictions, and fiscal years 2006 to 2018 remain open to examination by certain foreign taxing jurisdictions. The Company has been notified of upcoming examinations of the U.S. Federal income tax return for the year ended June 30, 2016 and the Switzerland Federal income tax returns for the years ended June 30, 2015 and 2016. The Company believes its income tax reserves for these tax matters are adequate.

U.S. Tax Reform

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act significantly revises the future ongoing U.S. corporate income tax by, among other things, lowering U.S. corporate income tax rates and implementing a territorial tax system. As the Company has a June 30 fiscal year-end, the lower corporate income tax rate will be phased in, resulting in a U.S. statutory federal rate of approximately 28% for the Company’s fiscal year ending June 30, 2018, and 21% for subsequent fiscal years. As part of the transition to the new territorial tax system, the Tax Act imposes a one-time repatriation tax on total post-1986 earnings and profits (“E&P”) of foreign subsidiaries that were previously deferred from U.S. income taxes.

At March 31, 2018, the Company has not finalized its accounting for the tax effects of the Tax Act; however, as described below, management has made a reasonable estimate of the effects on existing deferred tax balances and has recorded an estimated amount for its one-time repatriation tax, resulting in an increase in income tax expense. The Company has yet to complete its calculation of the total post-1986 foreign E&P. Further, the one-time repatriation tax is based in part on the amount of those earnings held in cash and other specified assets and could be impacted by the balance of those assets at June 30, 2018, which is not yet known. This amount may change when the Company finalizes the calculation of post-1986 foreign E&P previously deferred from U.S. taxation and the amounts held in cash or other specified assets as of June 30, 2018 are known.

The impact of the repatriation tax is expected to be offset by available net operating loss and credit carryforwards which currently have a valuation allowance. Thus, the tax expense reported is reduced by the release of the valuation allowance on U.S. deferred tax assets. The reduction of the U.S. corporate tax rate caused the Company to adjust the U.S. deferred tax assets and liabilities to the lower U.S. statutory federal rate of 21%. However, the Company will continue to analyze certain aspects of the Tax Act which could affect the measurement of these balances or give rise to new deferred tax amounts. In addition, the Company has recorded withholding taxes on planned repatriation due to the change to a territorial tax system. The $6.5 million income tax benefit recorded during the quarter ended March 31, 2018 for Tax Act was related to a change in the mix of forecasted income between U.S. and foreign sources for fiscal year 2018 resulting in a higher benefit for U.S. valuation allowance release being attributed to the Tax Act. The transitional impacts described above resulted in a cumulative provisional net charge of $9.3 million for the year to date March 31, 2018.

The changes included in the Tax Act are broad and complex. The final transition impacts of the Tax Act may differ from the estimates recorded through March 31, 2018, possibly materially, due to, among other things, changes in interpretations of the Tax Act, any legislative action to address questions that arise because of the Tax Act, any changes in accounting standards for income taxes or related interpretations in response to the Tax Act, or any updates or changes to estimates the Company has utilized to calculate the transition impacts, including impacts from changes to current year earnings estimates and foreign exchange rates of foreign subsidiaries. The Securities Exchange Commission has issued rules that allow for a measurement period of up to one year after the enactment date of the Tax Act to finalize the recording of the related tax impacts. The Company currently anticipates finalizing and recording any resulting adjustments by the end of the quarter ending December 31, 2018.

18

Note 9. | Earnings Per Share

The following table sets forth the computation of earnings per share for the periods indicated. Basic net income per share has been computed using the weighted average number of shares of common stock outstanding during the period. Diluted net income per share has been computed using the weighted average number of common shares outstanding during the period plus dilutive potential shares of common stock from (1) stock options, performance and restricted shares (under the treasury stock method) and (2) convertible debt (under the If Converted method) outstanding during the period. ($000 except per share data):

|  | Three Months Ended |  |  | Nine Months Ended |
|  | March 31, |  |  | March 31, |
|  | 2018 |  |  | 2017 |  |  | 2018 |  |  | 2017 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net earnings |  | $ | 30,098 |  |  | $ | 22,430 |  |  | $ | 60,835 |  |  | $ | 62,627 |
Numerator for basic income per share |  | $ | 30,098 |  |  | $ | 22,430 |  |  | $ | 60,835 |  |  | $ | 62,627 |
Effect of dilutive securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net of tax, on 0.25% Convertible Senior Notes due 2022 |  |  | 2,520 |  |  |  | - |  |  |  | - |  |  |  | - |
Numerator for diluted income per share |  | $ | 32,618 |  |  | $ | 22,430 |  |  | $ | 60,835 |  |  | $ | 62,627 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Denominator for basic income per share - weighted average shares |  |  | 62,427 |  |  |  | 62,807 |  |  |  | 62,491 |  |  |  | 62,403 |
Effect of dilutive securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dilutive effect of common stock equivalents |  |  | 2,624 |  |  |  | 2,203 |  |  |  | 2,633 |  |  |  | 1,930 |
0.25% Convertible Senior Notes due 2022 |  |  | 7,331 |  |  |  | - |  |  |  | - |  |  |  | - |
Dilutive potential common shares |  |  | 9,955 |  |  |  | 2,203 |  |  |  | 2,633 |  |  |  | 1,930 |
Denominator for diluted income per share |  |  | 72,382 |  |  |  | 65,010 |  |  |  | 65,124 |  |  |  | 64,333 |
Net earnings per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic earnings per common share |  | $ | 0.48 |  |  | $ | 0.36 |  |  | $ | 0.97 |  |  | $ | 1.00 |
Diluted earnings per common share |  | $ | 0.45 |  |  | $ | 0.35 |  |  | $ | 0.93 |  |  | $ | 0.97 |

The following table presents potential shares of common stock excluded from the calculation of diluted net income per share as their effect would have been anti-dilutive ($000):

|  | Three Months Ended |  |  | Nine Months Ended |
|  | March 31, |  |  | March 31, |
|  | 2018 |  |  | 2017 |  |  | 2018 |  |  | 2017 |
Stock options and restricted shares |  |  | 199 |  |  |  | 36 |  |  |  | 140 |  |  |  | 163 |
0.25% Convertible Senior Notes due 2022 |  |  | - |  |  |  | - |  |  |  | 7,331 |  |  |  | - |
Total anti-dilutive shares |  |  | 199 |  |  |  | 36 |  |  |  | 7,471 |  |  |  | 163 |

Note 10. | Segment Reporting

The Company reports its business segments using the “management approach” model for segment reporting. This means that the Company determines its reportable business segments based on the way the chief operating decision maker organizes business segments within the Company for making operating decisions and assessing performance.

The Company reports its financial results in the following three segments: (i) II-VI Laser Solutions, (ii) II-VI Photonics, and (iii) II-VI Performance Products, and the Company’s chief operating decision maker receives and reviews financial information based on these segments. The Company evaluates business segment performance based upon segment operating income, which is defined as earnings before income taxes, interest and other income or expense. The segments are managed separately due to the market, production requirements and facilities unique to each segment.

In June 2017, the Company completed its acquisition of IPI. See Note 3. Acquisitions and Investment. The operating results of this acquisition have been reflected in the selected financial information of the Company’s II-VI Photonics segment since the date of acquisition.

19

In August 2017, the Company completed its acquisition of II-VI Compound Semiconductor Ltd. See Note 3. Acquisitions and Investment. The operating results of this acquisition ha ve been reflected in the selected financial information of the Company’s II-VI Laser Solutions segment since the date of acquisition.

The accounting policies are consistent across each of the segments. The Company’s corporate expenses and assets are allocated to the segments. The Company evaluates segment performance based upon reported segment operating income, which is defined as earnings before income taxes, interest and other income or expense. Inter-segment sales and transfers are eliminated.

The following tables summarize selected financial information of the Company’s operations by segment ($000):

|  | Three Months Ended March 31, 2018 |
|  | II-VI |  |  |  |  |  |  | II-VI |  |  |  |  |  |  |  |  |
|  | Laser |  |  | II-VI |  |  | Performance |  |  |  |  |  |  |  |  |
|  | Solutions |  |  | Photonics |  |  | Products |  |  | Eliminations |  |  | Total |
Revenues |  | $ | 109,796 |  |  | $ | 116,778 |  |  | $ | 68,172 |  |  | $ | - |  |  | $ | 294,746 |
Inter-segment revenues |  |  | 8,256 |  |  |  | (501 | ) |  |  | 1,707 |  |  |  | (9,462 | ) |  |  | - |
Operating income |  |  | 9,932 |  |  |  | 16,637 |  |  |  | 8,169 |  |  |  | - |  |  |  | 34,738 |
Interest expense |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (5,014 | )
Other income (expense), net |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 1,496 |
Income taxes |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (1,122 | )
Net earnings |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 30,098 |
Depreciation and amortization |  |  | 10,306 |  |  |  | 5,651 |  |  |  | 3,967 |  |  |  | - |  |  |  | 19,924 |
Segment assets |  |  | 769,649 |  |  |  | 586,475 |  |  |  | 381,110 |  |  |  | - |  |  |  | 1,737,234 |
Expenditures for property, plant & equipment |  |  | 16,773 |  |  |  | 15,461 |  |  |  | 6,380 |  |  |  | - |  |  |  | 38,614 |
Investments |  |  | - |  |  |  | - |  |  |  | 68,222 |  |  |  | - |  |  |  | 68,222 |

|  | Three Months Ended March 31, 2017 |
|  | II-VI |  |  |  |  |  |  | II-VI |  |  |  |  |  |  |  |  |
|  | Laser |  |  | II-VI |  |  | Performance |  |  |  |  |  |  |  |  |
|  | Solutions |  |  | Photonics |  |  | Products |  |  | Eliminations |  |  | Total |
Revenues |  | $ | 83,648 |  |  | $ | 109,099 |  |  | $ | 52,240 |  |  | $ | - |  |  | $ | 244,987 |
Inter-segment revenues |  |  | 9,661 |  |  |  | 3,450 |  |  |  | 2,713 |  |  |  | (15,824 | ) |  |  | - |
Operating income |  |  | 8,337 |  |  |  | 15,898 |  |  |  | 4,804 |  |  |  | - |  |  |  | 29,039 |
Interest expense |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (1,936 | )
Other income (expense), net |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 2,164 |
Income taxes |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (6,837 | )
Net earnings |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 22,430 |
Depreciation and amortization |  |  | 5,713 |  |  |  | 5,029 |  |  |  | 4,182 |  |  |  | - |  |  |  | 14,924 |
Expenditures for property, plant & equipment |  |  | 23,299 |  |  |  | 8,727 |  |  |  | 9,287 |  |  |  | - |  |  |  | 41,313 |

|  | Nine Months Ended March 31, 2018 |
|  | II-VI |  |  |  |  |  |  | II-VI |  |  |  |  |  |  |  |  |
|  | Laser |  |  | II-VI |  |  | Performance |  |  |  |  |  |  |  |  |
|  | Solutions |  |  | Photonics |  |  | Products |  |  | Eliminations |  |  | Total |
Revenues |  | $ | 312,875 |  |  | $ | 337,912 |  |  | $ | 186,932 |  |  | $ | - |  |  | $ | 837,719 |
Inter-segment revenues |  |  | 22,270 |  |  |  | 10,991 |  |  |  | 3,691 |  |  |  | (36,952 | ) |  |  | - |
Operating income |  |  | 22,689 |  |  |  | 53,066 |  |  |  | 21,307 |  |  |  | - |  |  |  | 97,062 |
Interest expense |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (13,303 | )
Other income (expense), net |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 4,228 |
Income taxes |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (27,152 | )
Net earnings |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 60,835 |
Depreciation and amortization |  |  | 27,560 |  |  |  | 18,382 |  |  |  | 12,207 |  |  |  | - |  |  |  | 58,149 |
Expenditures for property, plant & equipment |  |  | 53,949 |  |  |  | 35,077 |  |  |  | 26,411 |  |  |  | - |  |  |  | 115,437 |

20

|  | Nine Months Ended March 31, 2017 |
|  | II-VI |  |  |  |  |  |  | II-VI |  |  |  |  |  |  |  |  |
|  | Laser |  |  | II-VI |  |  | Performance |  |  |  |  |  |  |  |  |
|  | Solutions |  |  | Photonics |  |  | Products |  |  | Eliminations |  |  | Total |
Revenues |  | $ | 244,421 |  |  | $ | 305,824 |  |  | $ | 148,084 |  |  | $ | - |  |  | $ | 698,329 |
Inter-segment revenues |  |  | 24,361 |  |  |  | 10,049 |  |  |  | 7,091 |  |  |  | (41,501 | ) |  |  | - |
Operating income |  |  | 22,628 |  |  |  | 45,689 |  |  |  | 11,549 |  |  |  | - |  |  |  | 79,866 |
Interest expense |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (4,547 | )
Other income (expense), net |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 9,611 |
Income taxes |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (22,303 | )
Net earnings |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 62,627 |
Depreciation and amortization |  |  | 17,025 |  |  |  | 14,853 |  |  |  | 12,844 |  |  |  | - |  |  |  | 44,722 |
Expenditures for property, plant & equipment |  |  | 59,161 |  |  |  | 21,224 |  |  |  | 18,750 |  |  |  | - |  |  |  | 99,135 |

Note 11. | Share-Based Compensation

The Company’s Board of Directors adopted the II-VI Incorporated Amended and Restated 2012 Omnibus Incentive Plan (the “Plan”), which was approved by the Company’s shareholders. The Plan provides for the grant of performance-based cash incentive awards, non-qualified stock options, stock appreciation rights, restricted share awards, restricted share units, deferred share awards, performance share awards and performance share units to employees, officers and directors of the Company. The maximum number of shares of the Company’s Common Stock authorized for issuance under the Plan is limited to 4,900,000 shares of Common Stock, not including any remaining shares forfeited under the predecessor plans that may be rolled into the Plan. The Company records share-based compensation expense for these awards in accordance with U.S. GAAP, which requires the recognition of grant-date fair value of share-based compensation in net earnings and over the requisite service period of the individual grantees, which generally equals the vesting period. The Company accounts for cash-based stock appreciation rights, cash-based restricted share unit awards and cash-based performance share unit awards as liability awards, in accordance with applicable accounting standards.

Share-based compensation expense is allocated approximately 20% to cost of goods sold and 80% to selling, general and administrative expense, based on the employee classification of the grantees. Share-based compensation expense for the periods indicated was as follows ($000):

|  | Three Months Ended |  |  | Nine Months Ended |
March 31, |  |  | 2018 |  |  |  | 2017 |  |  |  | 2018 |  |  |  | 2017 |
Stock Options and Cash-Based Stock Appreciation Rights |  | $ | 737 |  |  | $ | 1,565 |  |  | $ | 5,262 |  |  | $ | 4,659 |
Restricted Share Awards and Cash-Based Restricted Share Unit Awards |  |  | 1,381 |  |  |  | 1,890 |  |  |  | 6,125 |  |  |  | 5,450 |
Performance Share Awards and Cash-Based Performance Share Unit Awards |  |  | 1,468 |  |  |  | 1,110 |  |  |  | 3,908 |  |  |  | 2,438 |
|  | $ | 3,586 |  |  | $ | 4,565 |  |  | $ | 15,295 |  |  | $ | 12,547 |

Note 12. | Fair Value of Financial Instruments

The FASB defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous markets for the asset and liability in an orderly transaction between market participants at the measurement date. The Company estimates fair value of its financial instruments utilizing an established three-level hierarchy in accordance with U.S. GAAP. The hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date as follows:

• | Level 1 – | Valuation is based upon unadjusted quoted prices for identical assets or liabilities in active markets.
• | Level 2 – | Valuation is based upon quoted prices for similar assets and liabilities in active markets, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instruments.
• | Level 3 – | Valuation is based upon other unobservable inputs that are significant to the fair value measurements.

The classification of fair value measurements within the hierarchy is based upon the lowest level of input that is significant to the measurement.

21

In February 2016, the Company entered into a contingent earnout arrangement which provides up to a maximum o f $6.0 million of additional cash earnout opportunities based upon II-VI EpiWorks achieving certain agreed upon financial and operational targets for capacity, wafers output and gross margin, which if earned would be payable for the achievement of each spe cific annual target over the next three years. The Company paid the first year earnout amount of $2.0 million during the quarter ended June 30, 2017.

In June 2017, the Company entered into a contingent earnout arrangement which provides up to a maximum of $2.5 million of additional cash earnout opportunities based upon IPI achieving certain agreed upon financial and transitional objectives relating to finance, information technology and human resources, which if earned would be payable for the achievement of each specific annual target over the next year.

At March 31, 2018, the Company had foreign currency forward contracts recorded at fair value. The fair values of these instruments were measured using valuations based upon quoted prices for similar assets and liabilities in active markets (Level 2) and are valued by reference to similar financial instruments, adjusted for credit risk, restrictions and other terms specific to the contracts.

In November 2017, the Company acquired a 93.8% equity investment in a privately held company. The Company has the right to purchase all of the outstanding interest of each of the minority equity holders and the minority equity holders have the right to cause the Company to purchase all of their outstanding interests at any time on or after the third anniversary of the investment or earlier upon certain events. The Company performed a Monte Carlo simulation to estimate the fair value of the net put option at the investment date and recorded a liability of $2.2 million in “Other Liabilities” in the Condensed Consolidated Balance Sheet as of the acquisition date in accordance with ASC 815-10, Derivatives and Hedging. The fair value of the net put option is adjusted as necessary on a quarterly basis with any changes in the fair value recorded through earnings. The change in fair value of the net purchase option from the investment date to March 31, 2018 was not material.

The fair values of the contingent earnout arrangements and the net put option were measured using valuations based upon other unobservable inputs that are significant to the fair value measurement (Level 3).

The Company estimated the fair value of the 0.25% convertible notes based on quoted market prices as of the last trading day prior to March 31, 2018; however, the convertible notes have only a limited trading volume and as such this fair value estimate is not necessarily the value at which the convertible notes could be retired or transferred. The Company concluded that this fair value measurement should be categorized within Level 2. The carrying value of the convertible notes is net of unamortized discount and issuance costs. See Note 7. Debt for details on the Company’s debt facilities. The fair value and carrying value of the convertible notes were as follows at March 31, 2018 ($000):

|  | Fair Value |  |  | Carrying Value |
Convertible notes |  | $ | 377,775 |  |  | $ | 285,550 |

The following table provides a summary by level of the fair value of financial instruments that are measured on a recurring basis or for which fair value is disclosed for the periods presented ($000):

|  | Fair Value Measurements at March 31, 2018 Using: |
|  |  |  |  |  | Quoted Prices in |  |  | Significant |  |  |  |  |
|  |  |  |  |  | Active Markets |  |  | Other |  |  | Significant |
|  |  |  |  |  | for Identical |  |  | Observable |  |  | Unobservable |
|  |  |  |  |  | Assets |  |  | Inputs |  |  | Inputs |
|  | March 31, 2018 |  |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | $ | 271 |  |  | $ | - |  |  | $ | 271 |  |  | $ | - |
Contingent earnout arrangements |  | $ | 5,130 |  |  | $ | - |  |  | $ | - |  |  | $ | 5,130 |
Net put option |  | $ | 2,233 |  |  | $ | - |  |  | $ | - |  |  | $ | 2,233 |

22

|  | Fair Value Measurements at June 30, 2017 Using: |
|  |  |  |  |  | Quoted Prices in |  |  | Significant |  |  |  |  |
|  |  |  |  |  | Active Markets |  |  | Other |  |  | Significant |
|  |  |  |  |  | for Identical |  |  | Observable |  |  | Unobservable |
|  |  |  |  |  | Assets |  |  | Inputs |  |  | Inputs |
|  | June 30, 2017 |  |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | $ | 191 |  |  | $ | - |  |  | $ | 191 |  |  | $ | - |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent earnout arrangements |  | $ | 5,795 |  |  | $ | - |  |  | $ | - |  |  | $ | 5,795 |

The Company’s policy is to report transfers into and out of Levels 1 and 2 of the fair value hierarchy at fair values as of the beginning of the period in which the transfers occur. There were no transfers in and out of Levels 1 and 2 of the fair value hierarchy during the three months ended March 31, 2018.

The following table presents a reconciliation of the beginning and ending fair value measurements of the Company’s Level 3 contingent earnout arrangements related to the acquisition of II-VI EpiWorks and IPI and the net put option relating to the equity investment acquired in November 2017. ($000):

|  | Significant |
|  | Unobservable Inputs |
|  | (Level 3) |
Balance at July 1, 2017 |  | $ | 5,795 |
Contingent earnout arrangements: |  |  |  |
Purchase price adjustment - IPI |  |  | (25 | )
Net put option |  |  | 2,233 |
Changes in fair value recorded in other expense, (income) |  |  | (640 | )
Balance at March 31, 2018 |  | $ | 7,363 |

The fair values of cash and cash equivalents are considered Level 1 among the fair value hierarchy and approximate fair value because of the short-term maturity of those instruments. The Company’s borrowings including its capital lease obligation are considered Level 2 among the fair value hierarchy and their principal amounts approximate fair value.

Note 13. | Commitments and Contingencies

The Company records a warranty reserve as a charge against earnings based on a percentage of sales utilizing actual warranty claims over the last twelve months. The following table summarizes the change in the carrying value of the Company’s warranty reserve, which is a component of Other accrued liabilities in the Company’s Condensed Consolidated Balance Sheets ($000):

Nine Months Ended March 31, 2018 |  | Amount |
Balance-beginning of year |  | $ | 4,546 |
Settlements during the period |  |  | (3,065 | )
Additional warranty liability recorded |  |  | 2,404 |
Balance-end of period |  | $ | 3,885 |

23

Note 14. | Post-Retirement Benefits

The Company has a pension plan (the “Swiss Plan”) covering employees of the Zurich, Switzerland subsidiary. Net periodic pension costs associated with the Swiss Plan included the following ($000):

|  | Three Months Ended |  |  | Nine Months Ended |
|  | March 31, |  |  | March 31, |
|  | 2018 |  |  | 2017 |  |  | 2018 |  |  | 2017 |
Service cost |  | $ | 967 |  |  | $ | 874 |  |  | $ | 2,865 |  |  | $ | 2,642 |
Interest cost |  |  | 109 |  |  |  | 39 |  |  |  | 323 |  |  |  | 117 |
Expected return on plan assets |  |  | (218 | ) |  |  | (176 | ) |  |  | (646 | ) |  |  | (532 | )
Net amortization |  |  | (150 | ) |  |  | (189 | ) |  |  | - |  |  |  | 208 |
Net periodic pension costs |  | $ | 708 |  |  | $ | 548 |  |  | $ | 2,542 |  |  | $ | 2,435 |

The Company contributed $0.9 and $2.8 million to the Swiss Plan during the three and nine months ended March 31, 2018, respectively, and $0.8 million and $2.6 million during the three and nine months ended March 31, 2017, respectively. The Company currently anticipates contributing an additional estimated amount of approximately $0.9 million to the Swiss Plan during the remainder of fiscal year 2018.

Note 15. | Share Repurchase Programs

In August 2017, in conjunction with the Company’s offering and sale of the Notes, the Company’s Board of Directors authorized the Company to purchase up to $50 million of its Common Stock with a portion of the net proceeds received from the offering and sale of the Notes. The shares that were purchased by the Company pursuant to this authorization were retained as treasury stock and are available for general corporate purposes. The Company purchased 1,414,900 shares of its Common Stock for approximately $49.9 million pursuant to this authorization.

In August 2014, the Company’s Board of Directors authorized the Company to purchase up to $50 million of its Common Stock through a share repurchase program (the “Program”) that calls for shares to be purchased in the open market or in private transactions from time to time. The Program has no expiration and may be suspended or discontinued at any time. Shares purchased by the Company are retained as treasury stock and available for general corporate purposes. The Company did not repurchase shares pursuant to this Program during the nine months ended March 31, 2018. Through March 31, 2018, the Company has cumulatively purchased 1,316,587 shares of its Common Stock pursuant to the Program for approximately $19.0 million.

Note 16. | Accumulated Other Comprehensive Income (Loss)

The changes in accumulated other comprehensive income (“AOCI") by component, net of tax, for the nine months ended March 31, 2018 were as follows ($000):

|  | Foreign |  |  |  |  |  |  | Total |
|  | Currency |  |  | Defined |  |  | Accumulated Other |
|  | Translation |  |  | Benefit |  |  | Comprehensive |
|  | Adjustment |  |  | Pension Plan |  |  | Income (Loss) |
AOCI - June 30, 2017 |  | $ | (8,460 | ) |  | $ | (5,318 | ) |  | $ | (13,778 | )
Other comprehensive income before reclassifications |  |  | 30,885 |  |  |  | - |  |  |  | 30,885 |
Net current-period other comprehensive income |  |  | 30,885 |  |  |  | - |  |  |  | 30,885 |
AOCI - March 31, 2018 |  | $ | 22,425 |  |  | $ | (5,318 | ) |  | $ | 17,107 |

24

Note 17. | Capital Lease

The Company’s OptoElectronic Devices subsidiary entered into a capital lease related to a building in Warren, New Jersey. The following table shows the future minimum lease payments due under the non-cancelable capital lease ($000):

Fiscal Year Ending June 30, |  | Amount |
2018 (remaining) |  |  | 645 |
2019 |  |  | 2,579 |
2020 |  |  | 2,579 |
2021 |  |  | 2,579 |
2022 |  |  | 2,579 |
Thereafter |  |  | 24,503 |
Total minimum lease payments |  | $ | 35,464 |
Less amount representing interest |  |  | 11,770 |
Present value of capitalized payments |  | $ | 23,694 |
Less: current portion |  |  | 1,120 |
Long-term portion |  | $ | 22,574 |

The current and long-term portion of the capital lease obligation was recorded in Other accrued liabilities and Capital lease obligation, respectively, in the Company’s Condensed Consolidated Balance Sheet as of March 31, 2018. The present value of the minimum capital lease payments at inception was $25 million recorded in Property, Plant & Equipment, net, in the Company’s Condensed Consolidated Balance Sheet as of March 31, 2018, with associated depreciation being recorded over the 15-year life of the lease. During the three and nine months ended March 31, 2018, the Company recorded $0.4 million and $1.3 million, respectively, of depreciation expense associated with the capital leased asset.

25

Item 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIO N AND RESULTS OF OPERATIONS

Forward-Looking Statements

This Quarterly Report on Form 10-Q, including Management’s Discussion and Analysis of Financial Condition and Results of Operations (“Management’s Discussion and Analysis”), contains forward-looking statements as defined by Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding projected growth rates, markets, product development, financial position, capital expenditures and foreign currency exposure. Forward-looking statements are also identified by words such as “expects,” “anticipates,” “intends,” “plans,” “projects” or similar expressions.

Although our management considers these expectations and assumptions to be reasonable, actual results could differ materially from any such forward-looking statements included in this Quarterly Report on Form 10-Q or otherwise made by our management due to the following factors, among others: dependency on international sales and successful management of global operations; the development and use of new technology; the timely release of new products and acceptance of such new products by the market; our ability to devise and execute strategies to respond to market conditions; our ability to achieve the anticipated benefits of capital investments that we make; the impact of acquisitions on our business and our ability to assimilate recently acquired businesses; the impact of impairment in goodwill and indefinite-lived intangible assets in one or more of our segments; adverse changes in economic or industry conditions generally (including capital markets) or in the markets served by the Company; our ability to protect our intellectual property; domestic and foreign governmental regulation, including that related to the environment; the impact of a data breach incident on our operations; supply chain issues; the actions of competitors; the purchasing patterns of customers and end-users; the occurrence of natural disasters and other catastrophic events outside of our control; changes in local market laws and practices and risks related to the recent U.S. tax legislation and the Company’s continuing analysis of its impact on the Company and the adoption and expansion of trade restrictions or the occurrence of trade wars. There are additional risk factors that could materially affect the Company’s business, results of operations or financial condition as set forth in Part I, Item 1A of the Company’s most recent Annual Report on Form 10-K as filed with the Securities and Exchange Commission on August 21, 2017.

In addition, we operate in a highly competitive and rapidly changing environment; new risk factors can arise, and it is not possible for management to anticipate all such risk factors, nor to assess the impact of all such risk factors on our business or the extent to which any individual risk factor, or combination of risk factors, may cause results to differ materially from those contained in any forward-looking statement. The forward-looking statements included in this Quarterly Report on Form 10-Q are based only on information currently available to us and speak only as of the date of this Report. We do not assume any obligation, and do not intend to, update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by the securities laws. Investors should, however, consult any further disclosures of a forward-looking nature that the Company may make in its subsequent Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, or other disclosures filed with or furnished to the SEC.

Investors should also be aware that, while the Company does communicate with securities analysts from time to time, such communications are conducted in accordance with applicable securities laws. Investors should not assume that the Company agrees with any statement or report issued by any analyst irrespective of the content of the statement or report.

Introduction

II-VI Incorporated (“II-VI,” the “Company,” “we,” “us” or “our”), a worldwide leader in engineered materials and opto-electronic components, is a vertically integrated manufacturing company that develops innovative products for diversified applications in the industrial materials processing, optical communications, military, consumer electronics, semiconductor equipment, life science and automotive applications. The Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms, including integration with advanced software.

The Company generates revenues, earnings and cash flows from developing, manufacturing and marketing engineered materials and opto-electronic components for precision use in industrial, optical communications, military, semiconductor, medical and consumer applications. We also generate revenue, earnings and cash flows from government-funded research and development contracts relating to the development and manufacture of new technologies, materials and products.

Our customer base includes original equipment manufacturers, laser end users, system integrators of high-power lasers, manufacturers of equipment and devices for industrial, optical communications, consumer electronics, security and monitoring applications, U.S. government prime contractors, various U.S. government agencies and thermoelectric solutions suppliers.

26

In June 2017, the Company completed its acquisition of IPI. See Note 3. Acquisitions and Investment. The operating results o f this acquisition have been reflected in the selected financial information of the Company’s II-VI Photonics segment since the date of acquisition.

In August 2017, the Company completed its acquisition of II-VI Compound Semiconductors Ltd. See Note 3. Acquisitions and Investment. The operating results of this acquisition have been reflected in the selected financial information of the Company’s II-VI Laser Solutions segment since the date of acquisition.

Critical Accounting Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America and the Company’s discussion and analysis of its financial condition and results of operations require the Company’s management to make judgments, assumptions and estimates that affect the amounts reported in its condensed consolidated financial statements and accompanying notes. Note 1 of the Notes to Consolidated Financial Statements in the Company’s most recent Annual Report on Form 10-K describes the significant accounting policies and methods used in the preparation of the Company’s consolidated financial statements. There have been no changes in significant accounting policies as of March 31, 2018.

New Accounting Standards

See “Note 2. Recent Accounting Pronouncements” to our unaudited financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q for a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on our consolidated financial statements.

Results of Operations ($ in millions, except per share data)

The following tables set forth select items from our Condensed Consolidated Statements of Earnings for the three and nine months ended March 31, 2018 and 2017:

|  | Three Months Ended |  |  | Three Months Ended |
|  | March 31, 2018 |  |  | March 31, 2017 |
|  |  |  |  |  | % of |  |  |  |  |  |  | % of |
|  |  |  |  |  | Revenues |  |  |  |  |  |  | Revenues |
Total revenues |  | $ | 294.7 |  |  |  | 100.0 | % |  | $ | 245.0 |  |  |  | 100.0 | %
Cost of goods sold |  |  | 176.4 |  |  |  | 59.9 |  |  |  | 147.3 |  |  |  | 60.1 |
Gross margin |  |  | 118.3 |  |  |  | 40.2 |  |  |  | 97.7 |  |  |  | 39.9 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Internal research and development |  |  | 30.6 |  |  |  | 10.4 |  |  |  | 25.4 |  |  |  | 10.4 |
Selling, general and administrative |  |  | 53.1 |  |  |  | 18.0 |  |  |  | 43.3 |  |  |  | 17.7 |
Interest and other, net |  |  | 3.5 |  |  |  | 1.2 |  |  |  | (0.2 | ) |  |  | (0.1 | )
Earnings before income tax |  |  | 31.1 |  |  |  | 10.6 |  |  |  | 29.2 |  |  |  | 11.9 |
Income taxes |  |  | 1.2 |  |  |  | 0.4 |  |  |  | 6.8 |  |  |  | 2.8 |
Net earnings |  | $ | 30.1 |  |  |  | 10.2 | % |  | $ | 22.4 |  |  |  | 9.1 | %
Diluted earnings per share |  | $ | 0.45 |  |  |  |  |  |  | $ | 0.35 |  |  |  |  |

27

|  | Nine Months Ended |  |  | Nine Months Ended |
|  | March 31, 2018 |  |  | March 31, 2017 |
|  |  |  |  |  | % of |  |  |  |  |  |  | % of |
|  |  |  |  |  | Revenues |  |  |  |  |  |  | Revenues |
Total revenues |  | $ | 837.7 |  |  |  | 100.0 | % |  | $ | 698.3 |  |  |  | 100.0 | %
Cost of goods sold |  |  | 503.9 |  |  |  | 60.2 |  |  |  | 418.8 |  |  |  | 60.0 |
Gross margin |  |  | 333.8 |  |  |  | 39.8 |  |  |  | 279.5 |  |  |  | 40.0 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Internal research and development |  |  | 83.9 |  |  |  | 10.0 |  |  |  | 70.8 |  |  |  | 10.1 |
Selling, general and administrative |  |  | 152.8 |  |  |  | 18.2 |  |  |  | 128.9 |  |  |  | 18.5 |
Interest and other, net |  |  | 9.1 |  |  |  | 1.1 |  |  |  | (5.1 | ) |  |  | (0.7 | )
Earnings before income tax |  |  | 88.0 |  |  |  | 10.5 |  |  |  | 84.9 |  |  |  | 12.2 |
Income taxes |  |  | 27.2 |  |  |  | 3.2 |  |  |  | 22.3 |  |  |  | 3.2 |
Net earnings |  | $ | 60.8 |  |  |  | 7.3 | % |  | $ | 62.6 |  |  |  | 9.0 | %
Diluted earnings per share |  | $ | 0.93 |  |  |  |  |  |  | $ | 0.97 |  |  |  |  |

Executive Summary

Net earnings for the three months ended March 31, 2018 were $30.1 million ($0.45 per share diluted), compared to $22.4 million ($0.35 per share diluted) for the same period last fiscal year. Net earnings for the nine months ended March 31, 2018 were $60.8 million ($0.93 per share diluted), compared to $62.6 million ($0.97 per share diluted) for the nine months ended March 31, 2017.

During December 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law by the President of the United States. The Tax Act imposes a one-time repatriation tax on deemed repatriation of historical earnings of foreign subsidiaries. The impact of the repatriation tax is expected to be offset by available net operating loss and credit carryforwards which currently have valuation allowances. Thus the tax expense reported is reduced by the release of the valuation allowances on U.S. deferred tax assets. The reduction of the U.S. corporate tax rate caused us to adjust our U.S. deferred tax assets and liabilities to the lower federal base rate of 21%. In addition, the Company has recorded withholding taxes on planned repatriation due to the change to a territorial tax system. These transitional impacts resulted in a provisional net (benefit) of ($6.5) million (($.09) per share diluted) and $9.3 million ($0.14 per share diluted), for the three and nine months ended March 31, 2018, respectively.

Exclusive of the impact from income taxes, net earnings were favorably impacted by the incremental revenues recognized for both the current three and nine month periods due to increased demand from customers in the industrial material, communication, semiconductor capital equipment and RF and power generation markets. The financial results include the acquisitions of IPI and II-VI Compound Semiconductor Ltd. for the current fiscal periods. These two acquisitions contributed $5.8 million and $17.7 million in revenues, respectively, and $3.4 million and $8.2 million in net losses, respectively, for the three and nine months ended March 31, 2018. The net losses for these acquisitions were at the II-VI Compound Semiconductor Ltd. business as the Company continues to invest in internal research and development for new material technology platforms to address the anticipated growing consumer electronics markets.

Consolidated

Revenues. Revenues for the three months ended March 31, 2018 increased 20% to $294.7 million, compared to $245.0 million for the same period last fiscal year. Revenues for the nine months ended March 31, 2018 increased 20% to $837.7 million, compared to $698.3 million for the same period last fiscal year. The increase in revenues for both the three and nine month periods ended March 31, 2018 compared to the same periods last fiscal year were the result of strong demand from customers across its business units. The Company has experienced increased demand from its industrial based customers for CO2, fiber and direct diode optics and components as well silicon carbide (“SiC”) substrates supporting radio frequency (“RF”) and power generation device products for industrial and automotive markets.

28

Gross margin. Gross margin for the three months ended March 31, 2018 was $118.3 million, or 40.2% of total revenues, compared to $97.7 million, or 39.9% of total revenues, for the same period last fiscal year. Gross margin for the nine months ended March 31, 2018 was $333.8 million, or 39.8% of total revenues, compared to $279.5 million or 40.0% of total revenues, for the same period last fiscal year. The increase in gross margin dollars for both the three and nine months ended March 31, 2018, compared to the same periods last fiscal year was due to the 20% revenue increase for b oth periods. Gross margin as a percentage of revenues was relatively flat due to increased operating costs incurred during the current fiscal periods related to the impact of foreign currency and production yield challenges and inefficiencies.

Internal research and development. Internal research and development expenses for the three months ended March 31, 2018 were $30.6 million, or 10.4% of revenues, compared to $25.4 million, or 10.4% of revenues, for the same period last fiscal year. Internal research and development expenses for the nine months ended March 31, 2018 were $83.9 million, or 10.0% of revenues, compared to $70.8 million, or 10.1% of revenues, for the same period last fiscal year. The increase in expense for both the three and nine month periods is primarily the result of the acquisition of II-VI Compound Semiconductor Ltd. which has begun ramping its investment to address new and growing technologies in the consumer electronics, communications and automotive markets.

Selling, general and administrative. Selling, general and administrative (“SG&A”) expenses for the three months ended March 31, 2018 were $53.1 million, or 18.0% of revenues, compared to $43.3 million, or 17.7% of revenues, for the same period last fiscal year. SG&A expenses for the nine months ended March 31, 2018 were $152.8 million, or 18.2% of revenues, compared to $128.9 million, or 18.5% of revenues. SG&A includes $1.5 million and $4.7 million, respectively, for the three and nine months ended March 31, 2018 for the combined acquisitions of Integrated Photonics, Inc. and Compound Semiconductor Ltd. Exclusive of the acquisitions, the increase in SG&A for both periods is primarily due to increased operating costs to support the Company’s growing revenue and infrastructure base. The Company is aggressively working to identify and capitalize on synergies created from the Company’s recent acquisitions and working to improve the leverage in fiscal year 2018 and beyond.

Interest and other, net. Interest and other, net for the three months ended March 31, 2018 was expense of $3.5 million, compared to income of $0.2 million for the same period last fiscal year. Interest and other, net for the nine months ended March 31, 2018 was expense of $9.1 million compared to income of $5.1 million for the same period last fiscal year. Included in interest and other, net, were interest expense on borrowings, earnings from equity investments, interest income on excess cash reserves, unrealized gains and losses on the Company’s deferred compensation plan, and foreign currency gains and losses. Interest expense increased $3.1 million and $8.8 million, respectively, for the current three and nine months due to the higher level of the Company’s outstanding debt. For the nine months ended March 31, 2017, other income consisted primarily of foreign currency gains of $3.6 million and income from the residual agreements on the sale of the RF business of $4.8 million offset by interest expense on long-term borrowings of $4.5 million.

Income taxes. The Company’s year-to-date effective income tax rate at March 31, 2018 was 30.9%, compared to an effective tax rate of 26.3% for the same period last fiscal year. The variation between the Company’s effective tax rate and the new U.S. statutory rate of approximately 28% (blend of 35% and 21% tax rates) was primarily due to the impact of the U.S. enacted tax legislation and consolidation of the Company’s foreign operations, which are subject to income taxes at lower statutory rates. The prior year’s effective income tax rate was negatively impacted by the valuation allowance established for the benefit of losses from the Company’s U.S. entities.

Segment Reporting

Revenues and operating income for the Company’s reportable segments are discussed below. Operating income differs from net earnings in that operating income excludes certain operational expenses included in other expense (income) – net as reported. Management believes operating income to be a useful measure for investors, as it reflects the results of segment performance over which management has direct control and is used by management in its evaluation of segment performance. See “Note 10. Segment Reporting,” to our unaudited financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q for further information on the Company’s reportable segments and for the reconciliation of the Company’s operating income to net earnings, which is incorporated herein by reference.

29

II- VI Laser Solutions ($ in millions)

|  | Three Months Ended |  |  | % |  |  | Nine Months Ended |  |  | % |
|  | March 31, |  |  | Increase |  |  | March 31, |  |  | Increase |
|  | 2018 |  |  | 2017 |  |  |  |  |  |  | 2018 |  |  | 2017 |  |  |  |  |
Revenues |  | $ | 109.8 |  |  | $ | 83.6 |  |  |  | 31 | % |  | $ | 312.9 |  |  | $ | 244.4 |  |  |  | 28 | %
Operating income |  | $ | 9.9 |  |  | $ | 8.3 |  |  |  | 19 | % |  | $ | 22.7 |  |  | $ | 22.6 |  |  |  | - | %

The above operating results for the three and nine months ended March 31, 2018 include the Company’s acquisition of II-VI Compound Semiconductor Ltd. which was acquired in August 2017.

Revenues for the three months ended March 31, 2018 for II-VI Laser Solutions increased 31% to $109.8 million, compared to revenues of $83.6 million for the same period last fiscal year. Revenues for the nine months ended March 31, 2018 for II-VI Laser Solutions increased 28% to $312.9 million compared to $244.4 million for the same period last fiscal year. The increase in revenues for the three and nine months ended March 31, 2018 compared to the same periods last fiscal year was the result of increased demand from industrial based customers for carbon dioxide, fiber and direct diode laser optics and components. In addition, the segment has seen growing demand for CVD diamond optics used in the extreme ultraviolet lithography markets as well as vertical cavity surface emitting lasers used in consumer electronics, datacom and other end markets.

Operating income for the three months ended March 31, 2018 for II-VI Laser Solutions increased 19% to $9.9 million, compared to $8.3 million for the same period last fiscal year. Operating income for the nine months ended March 31, 2018 of $22.7 million was consistent with the prior year of $22.6 million. The increase in operating income for the three months ended March 31, 2018 compared to the same period last fiscal year was the result of incremental margin realized on the increased revenue levels. Offsetting operating income for the three months was $4.8 million of investments in internal research and development at Compound Semiconductor Ltd. addressing new consumer electronic and other technological markets.

II-VI Photonics ($ in millions)

|  | Three Months Ended |  |  | % |  |  | Nine Months Ended |  |  | % |
|  | March 31, |  |  | Increase |  |  | March 31, |  |  | Increase |
|  | 2018 |  |  | 2017 |  |  |  |  |  |  | 2018 |  |  | 2017 |  |  |  |  |
Revenues |  | $ | 116.8 |  |  | $ | 109.1 |  |  |  | 7 | % |  | $ | 337.9 |  |  | $ | 305.8 |  |  |  | 10 | %
Operating income |  | $ | 16.7 |  |  | $ | 15.9 |  |  |  | 5 | % |  | $ | 53.1 |  |  | $ | 45.7 |  |  |  | 16 | %

The above operating results for the three and nine months ended March 31, 2018 include the Company’s recent acquisition of IPI which was acquired in June 2017.

Revenues for the three months ended March 31, 2018 for II-VI Photonics increased 7% to $116.8 million, compared to $109.1 million for the same period last fiscal year. Revenues for the nine months ended March 31, 2018 increased 10% to $337.9 million compared to $305.8 million for the same period last fiscal year. Included in revenues for the three and nine months ended March 31, 2018 were $4.9 million and $15.2 million of revenues from the acquisition of IPI. Exclusive of the acquisition, the increase in revenues was primarily attributable to increased demand of optics and optical assemblies for applications for industrial lasers production.

Operating income for the three months ended March 31, 2018 for II-VI Photonics increased 5% to $16.7 million, compared to $15.9 million for the same period last fiscal year. Operating income for the nine months ended March 31, 2018 increased 16% to $53.1 million compared to $45.7 million for the same periods last fiscal year. The increase in operating income for both the three and nine month periods ended March 31, 2018 was primarily due to incremental margin realized on increased revenues.

II-VI Performance Products ($ in millions)

|  | Three Months Ended |  |  | % |  |  | Nine Months Ended |  |  | % |
|  | March 31, |  |  | Increase |  |  | March 31, |  |  | Increase |
|  | 2018 |  |  | 2017 |  |  |  |  |  |  | 2018 |  |  | 2017 |  |  |  |  |
Revenues |  | $ | 68.1 |  |  | $ | 52.3 |  |  |  | 30 | % |  | $ | 186.9 |  |  | $ | 148.1 |  |  |  | 26 | %
Operating income |  | $ | 8.2 |  |  | $ | 4.8 |  |  |  | 71 | % |  | $ | 21.3 |  |  | $ | 11.5 |  |  |  | 85 | %

30

Revenues for the three months ended March 31, 2018 for II-VI Performance Products increased 30% to $68.1 million compared to $52.3 million for the same period last fiscal year. Revenues for the nine months ended March 31, 2018 increased 26% to $186.9 million compared to $148.1 million for the same period last fiscal year. The increase in revenues for both th e three and nine month periods ended March 31, 2018 compared to the same periods last fiscal year was driven by increased demand for SiC products addressing RF electronics and high-power switching and power conversion systems for automotive, communications and military markets. In addition, the segment has seen an increased demand for products and components for the semiconductor capital equipment and military markets.

Operating income for the three months ended March 31, 2018 for II-VI Performance Products increased 71% to $8.2 million, compared to $4.8 million for the same period last fiscal year. Operating income for the nine months ended March 31, 2018 increased 85% to $21.3 million compared to $11.5 million for the same period last fiscal year. The increase in operating income for both the three and nine month periods ended March 31, 2018 was driven primarily by increased sales volume as well as favorable product mix towards higher margin products.

Liquidity and Capital Resources

Historically, our primary sources of cash have been from operations and long-term borrowing. Other sources of cash include proceeds received from the exercises of stock options and sale of equity instruments and proceeds received on earnout arrangements. Our historic uses of cash have been for capital expenditures, investment in research and development, business acquisitions, payments of principal and interest on outstanding debt obligations and purchases of treasury stock. Supplemental information pertaining to our sources and uses of cash for the periods indicated is presented as follows:

Sources (uses) of Cash (millions):

|  | Nine Months Ended |
|  | March 31, |
|  | 2018 |  |  | 2017 |
Net cash provided by operating activities |  | $ | 113.9 |  |  | $ | 78.4 |
Net proceeds on long-term borrowings |  |  | 168.0 |  |  |  | 44.0 |
Proceeds from exercises of stock options |  |  | 8.8 |  |  |  | 14.6 |
Additions to property, plant & equipment |  |  | (116.5 | ) |  |  | (99.1 | )
Purchases of businesses |  |  | (80.5 | ) |  |  | (0.6 | )
Purchase of equity investment |  |  | (51.7 | ) |  |  | - |
Purchases of treasury shares |  |  | (49.9 | ) |  |  | - |
Debt issuance costs |  |  | (10.1 | ) |  |  | (1.4 | )
Payments in satisfaction of employees' minimum tax obligations |  |  | (4.0 | ) |  |  | (3.4 | )
Effect of exchange rate changes on cash and cash equivalents and other items |  |  | 13.4 |  |  |  | (3.4 | )

Net cash provided by operating activities:

Net cash provided by operating activities was $113.9 million for the nine months ended March 31, 2018, compared to net cash provided by operating activities of $78.4 million for the same period last fiscal year. The increase in cash flow from operations during the current fiscal year is the result of improved working capital management relating to accounts receivable collections and payable management. In addition, the Company had increased non-cash adjustments for depreciation, amortization and share-based compensation expense in the current fiscal year.

Net cash used in investing activities:

Net cash used in investing activities was $248.2 million for the nine months ended March 31, 2018, compared to net cash used of $98.0 million for the same period last fiscal year. The net cash used in investing activities during the nine months ended March 31, 2018 included $116.5 million of cash paid for investments in capital expenditures, $80.5 million of cash paid for the acquisition of II-VI Compound Semiconductor Ltd. and $51.7 million for a 93.8% equity investment in a U.S. based technology company. The net cash used for the nine months ended March 31, 2017 primarily related to additions to property, plant & equipment.

31

Net cash provided by financing activities:

Net cash provided by financing activities was $112.9 million for the nine months ended March 31, 2018, compared to net cash provided by financing activities of $53.8 million for the same period last fiscal year. During the current fiscal year, the Company completed its offering and sale of $345 million aggregate principal amount of convertible notes. In addition, the Company borrowed $100 million on its revolving credit facility to fund its investments in capital expenditures and its investments in technology platforms. The net proceeds from the convertible debt offering as well as cash generated from operations was used to repay $262 million on the revolver, $15 million on the term loan, and $10.1 million of debt issuance costs and to repurchase $49.9 million of Common Stock. The Company also realized $8.8 million of proceeds from the exercise of stock options offset by $4.0 million on payments in satisfaction of employees’ minimum tax obligations. Net cash provided by financing activities during the nine months ended March 31, 2017 includes net proceeds on borrowing of $44.0 million and $14.6 million of cash received from exercise of stock options offset by $4.8 of payments in satisfaction of employees minimum tax obligations and debt issuance costs.

0.25% Convertible Senior Notes

On August 24, 2017, the Company entered into a purchase agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representative of the several initial purchasers named therein (collectively, the “Initial Purchasers”), to issue and sell $300 million aggregate principal amount of our 0.25% convertible senior notes due 2022 (the "Notes") in a private placement to qualified institutional buyers within the meaning of Rule 144A under the Securities Act of 1933, as amended. In addition, we granted the Initial Purchasers a 30-day option to purchase up to an additional $45 million aggregate principal amount of the Notes (the “Over-Allotment Option”).

On August 29, 2017, the Initial Purchasers exercised their Over-Allotment Option to purchase the entire $45 million in aggregate principal amount of additional Notes. The Notes mature on September 1, 2022, unless earlier repurchased by the Company or converted by holders in accordance with the terms of the Notes. Interest is payable semi-annually in arrears on March 1 and September 1 of each year, beginning on March 1, 2018.

The sale of the Notes to the Initial Purchasers settled on August 29, 2017, and resulted in approximately $336 million in net proceeds to the Company after deducting the initial purchasers’ discount and the estimated offering expenses. The net proceeds from the offering and sale of the Notes were used, in part, to repurchase approximately $49.9 million of our Common Stock. The Company used the remaining net proceeds to repay $252 million on its revolving credit facility and to pay debt issuance costs of $10.1 million.

The Notes are governed by an Indenture between the Company, as issuer, and U.S. Bank, National Association, as trustee. The Notes are our senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Notes; equal in right of payment to any of our indebtedness that is not so subordinated; effectively junior in right of payment to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of our subsidiaries. In the event of our bankruptcy, liquidation, reorganization or other winding up, our assets that secure secured debt will be available to pay obligations on the Notes only after all indebtedness under such secured debt has been repaid in full from such assets. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of our Common Stock or a combination of cash and shares of our Common Stock, at the Company’s election.

As a result of our cash conversion option, the Company separately accounted for the value of the embedded conversion option as a debt discount. The value of the embedded conversion option was determined based on the estimated fair value of the debt without the conversion feature, which was determined using an expected present value technique (income approach) to estimate the fair value of similar nonconvertible debt; the debt discount is being amortized as additional non-cash interest expense over the term of the Notes using the effective interest method with an effective interest rate of 4.5% per annum.

The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The initial conversion rate is 21.25 shares of Common Stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of $47.06 per share of Common Stock. Throughout the term of the Notes, the conversion rate may be adjusted upon the occurrence of certain events.

Holders of the Notes will not receive any cash payment representing accrued and unpaid interest upon conversion of a note. Accrued but unpaid interest will be deemed to be paid in full upon conversion rather than cancelled, extinguished or forfeited.

32

Prior to the close of business on the business day immediately preceding June 1, 2022, the Notes will be convertible only upon satisfaction of at least one of the conditions as follows:

| a) | During any fiscal quarter (and only during such fiscal quarter), if the last reported sale price of our Common Stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

| b) | During the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our Common Stock and the conversion rate on each such trading day; or

| c) | Upon the occurrence of specified corporate events.

On or after June 1, 2022 until the close of business on the business day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.

As of March 31, 2018, the Notes are not yet convertible. The Notes will become convertible upon the satisfaction of at least one of the above conditions. In accounting for the transaction costs related to the Note issuance, the Company allocated the total amount of offering costs incurred to the debt and equity components based on their relative values. Offering costs attributable to the debt component, totaling $8.4 million, are being amortized as non-cash interest expense over the term of the Notes, and offering costs attributable to the equity component, totaling $1.7 million, were recorded within Shareholders' equity.

The following table sets forth total interest expense recognized related to the Notes for the three months ended March 31, 2018:

|  |  | Three Months Ended March 31, 2018 |  |  | Nine Months Ended March 31, 2018 |
0.25% contractual coupon |  |  | $ | 216 |  |  | $ | 513 |
Amortization of debt discount and debt issuance costs including initial purchaser discount |  |  |  | 2,974 |  |  |  | 7,017 |
Interest expense |  |  | $ | 3,190 |  |  | $ | 7,530 |

Amended Credit Facility

On July 28, 2016, the Company amended and restated its existing credit agreement. The Third Amended and Restated Credit Agreement (the “Amended Credit Facility”) provides for a revolving credit facility of $325 million, as well as a $100 million term loan. The term loan is being repaid in consecutive quarterly principal payments on the first business day of each January, April, July and October, with the first payment having commenced on October 1, 2016, as follows: (i) twenty consecutive quarterly installments of $5 million and (ii) a final installment of all remaining principal due and payable on the maturity date of July 27, 2021. Amounts borrowed under the revolving credit facility are due and payable on the maturity date. The Amended Credit Facility is unsecured, but is guaranteed by each existing and subsequently acquired or organized wholly-owned domestic subsidiary of the Company. The Company has the option to request an increase to the size of the revolving credit facility in an aggregate additional amount not to exceed $100 million. The Amended Credit Facility has a five-year term through July 27, 2021 and has an interest rate of either a Base Rate Option or a Euro-Rate Option, plus an Applicable Margin, as defined in the agreement governing the Amended Credit Facility. If the Base Rate option is selected for a borrowing, the Applicable Margin is 0.00% to 1.25% and if the Euro-Rate Option is selected for a borrowing, the Applicable Margin is 1.00% to 2.25%. The Applicable Margin is based on the ratio of the Company’s consolidated indebtedness to consolidated EBITDA. Additionally, the Credit Facility is subject to certain covenants, including those relating to minimum interest coverage and maximum leverage ratios. As of March 31, 2018, the Company was in compliance with all financial covenants under its Amended Credit Facility.

Yen Loan

The Company’s Yen denominated line of credit is a 500 million Yen (approximately $4.7 million) facility. The Yen line of credit matures in August 2020. The interest rate is equal to LIBOR, as defined in the loan agreement, plus 0.625% to 1.75%. At March 31, 2018 and June 30, 2017, the Company had 300 million Yen borrowed. Additionally, the facility is subject to certain covenants, including those relating to minimum interest coverage and maximum leverage ratios. As of March 31, 2018, the Company was in compliance with all financial covenants under its Yen facility.

33

Aggregate Availability

The Company had aggregate availability of $236.4 million and $73.5 million under its lines of credit as of March 31, 2018 and June 30, 2017, respectively. The amounts available under the Company’s lines of credit are reduced by outstanding letters of credit. The total outstanding letters of credit supported by these credit facilities were $0.4 million and $1.2 million as of March 31, 2018 and June 30, 2017, respectively.

Weighted Average Interest Rate

The weighted average interest rate of total borrowings was 1.4% and 2.3% for the three months ended March 31, 2018 and 2017, respectively.

Share Repurchase Programs

In August 2017, in conjunction with the Company’s offering and sale of the Notes, the Company’s Board of Directors authorized the Company to purchase up to $50 million of its Common Stock with a portion of the net proceeds received from the offering and sale of the Notes. The shares that were purchased by the Company pursuant to this authorization were retained as treasury stock and are available for general corporate purposes. The Company purchased 1,414,900 shares of its Common Stock for approximately $49.9 million pursuant to this authorization.

In August 2014, the Company’s Board of Directors authorized the Company to purchase up to $50 million of its Common Stock through a share repurchase program (the “Program”) that calls for shares to be purchased in the open market or in private transactions from time to time. The Program has no expiration and may be suspended or discontinued at any time. Shares purchased by the Company are retained as treasury stock and available for general corporate purposes. The Company did not repurchase shares pursuant to this Program during the six months ended March 31, 2018. Through March 31, 2018, the Company has cumulatively purchased 1,316,587 shares of its Common Stock pursuant to the Program for approximately $19.0 million.

The Company’s cash position, borrowing capacity and debt obligations for the periods indicated were as follows (in millions):

|  | March 31, |  |  | June 30, |
|  | 2018 |  |  | 2017 |
Cash and cash equivalents |  | $ | 263.2 |  |  | $ | 271.9 |
Available borrowing capacity |  |  | 236.4 |  |  |  | 73.5 |
Total debt obligation |  |  | 511.7 |  |  |  | 343.5 |

The Company believes that cash flow from operations, existing cash reserves and available borrowing capacity will allow the Company to fund its working capital needs, capital expenditures, repayment of scheduled long-term borrowings and capital lease obligations, investments in internal research and development, share repurchases and growth objectives for the next twelve months.

The Company’s cash and cash equivalent balances are generated and held in numerous locations throughout the world, including amounts held outside the United States. As of March 31, 2018 and June 30, 2017, the Company held approximately $215 million and $245 million, respectively, of cash and cash equivalents outside of the United States. Cash balances held outside the United States could be repatriated to the United States. The recently enacted “Tax Cuts and Jobs Act” created significant changes to the taxation of undistributed foreign earnings and could change our future intentions regarding repatriation of earnings. The Company is currently evaluating the full impact of the new tax laws and will update future cash repatriation intentions as the Company further understands the new law.

Contractual Obligations

The following table presents information about the Company’s contractual obligations and commitments as of March 31, 2018.

34

Tabular-Disclosure of Contractual Obligations

|  | Payments Due By Period |
|  |  |  |  |  | Less Than 1 |  |  | 1-3 |  |  | 3-5 |  |  | More Than 5 |
Contractual Obligations |  | Total |  |  | Year |  |  | Years |  |  | Years |  |  | Years |
($000) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Long-term debt obligations |  | $ | 511,659 |  |  | $ | 20,000 |  |  | $ | 46,659 |  |  | $ | 100,000 |  |  | $ | 345,000 |
Interest payments(1) |  |  | 31,183 |  |  |  | 7,501 |  |  |  | 12,991 |  |  |  | 5,443 |  |  |  | 5,248 |
Capital lease obligations |  |  | 23,694 |  |  |  | 1,120 |  |  |  | 2,463 |  |  |  | 2,792 |  |  |  | 17,319 |
Operating lease obligations(2) |  |  | 126,397 |  |  |  | 18,727 |  |  |  | 32,597 |  |  |  | 20,925 |  |  |  | 54,148 |
Purchase obligations(3) (4) (5) |  |  | 122,842 |  |  |  | 115,440 |  |  |  | 7,402 |  |  |  | - |  |  |  | - |
Other long-term liabilities reflected on the Registrant's balance sheet under GAAP |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Total |  | $ | 815,775 |  |  | $ | 162,788 |  |  | $ | 102,112 |  |  | $ | 129,160 |  |  | $ | 421,715 |

(1) | Interest payments represent both variable and fixed rate interest obligations based on the interest rate in place at March 31, 2018 relating to the Amended Credit Facility, the 0.25% convertible notes and interest relating to the Company’s capital lease obligation.

(2) | Includes an obligation for the use of two parcels of land related to II-VI Performance Metals. The lease obligations extend through 2039 and 2061, respectively.

(3) | A purchase obligation is defined as an agreement to purchase goods or services that is enforceable and legally binding on the Company and that specifies all significant terms, including fixed or minimum quantities to be purchased; minimum or variable price provisions, and the approximate timing of the transaction. These amounts are primarily composed of open purchase order commitments to vendors for the purchase of supplies and materials.

(4) | Includes cash earnout opportunities based upon II-VI EpiWorks and IPI for the achievement of certain agreed upon financial and operational targets.

(5) | Includes the intention to acquire CoAdna, Inc during the first quarter of fiscal year 2019 in a cash transaction valued at approximately $85.0 million, net of any cash acquired.

The Company’s gross unrecognized income tax benefit at March 31, 2018 has been excluded from the table above because the Company is not currently able to reasonably estimate the amount by which the liability will increase or decrease over time. However, at this time, the Company does not expect a significant payment related to these obligations within the next year.

Pension obligations are not included in the table above. The Company expects the remaining defined benefit plan employer contributions for fiscal year 2018 to be $0.9 million. Estimated funding obligations are determined by asset performance, workforce and retiree demographics, tax and employment laws and other actuarial assumptions which may change the annual funding obligations.

Item 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

MARKET RISKS

The Company is exposed to market risks arising from adverse changes in foreign currency exchange rates and interest rates. In the normal course of business, the Company uses a variety of techniques and derivative financial instruments as part of its overall risk management strategy, which is primarily focused on its exposure in relation to the Japanese Yen, Chinese Renminbi, and the Euro. No significant changes have occurred in the techniques and instruments used other than those described below.

Foreign Exchange Risks

In the normal course of business, the Company enters into foreign currency forward exchange contracts with its financial institutions. The purpose of these contracts is to hedge ordinary business risks regarding foreign currencies on product sales. Foreign currency exchange contracts are used to limit transactional exposure to changes in currency rates.

35

Japanese Yen

The Company enters into foreign currency forward contracts that permit it to sell specified amounts of Japanese Yen expected to be received from its export sales for pre-established U.S. dollar amounts at specified dates. The forward contracts are denominated in the same foreign currencies in which export sales are denominated. These contracts provide the Company with an economic hedge in which settlement will occur in future periods, thereby limiting the Company’s exposure. These contracts had a total notional amount of $9.1 million and $12.7 million at March 31, 2018 and June 30, 2017, respectively.

A 10% change in the Yen to U.S. dollar exchange rate would have changed revenues in the range from a decrease of $5.8 million to an increase of $7.1 million for the nine months ended March 31, 2018.

Chinese Renminbi

The Company enters into month-to-month forward contracts at varying amounts maturing monthly to limit exposure to the Chinese Renminbi. The Company has recorded $4.1 million of unrealized foreign currency gain in the Condensed Consolidated Statement of Earnings related to these contracts for the nine months ended March 31, 2018.

Euro

The Company enters into month-to-month forward contracts at varying amounts maturing monthly to limit exposure to the Euro. The Company has recorded $0.8 million of unrealized foreign currency gains in the Condensed Consolidated Statement of Earnings related to these contracts for the nine months ended March 31, 2018.

The Company has short-term intercompany notes that are denominated in U.S. dollars with one of the Company’s European subsidiaries. A 10% change in the Euro to U.S. dollar exchange rate would have changed net earnings in the range from a decrease of $0.6 million to an increase of $0.7 million for the nine months ended March 31, 2018.

The Company monitors its positions and the credit ratings of the parties to these contracts. While the Company may be exposed to potential losses due to risk in the event of non-performance by the counterparties to these financial instruments, it does not currently anticipate such losses.

Assets and liabilities of foreign operations are translated into U.S. dollars using the period-end exchange rate, while income and expenses are translated using the average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income within Shareholders’ equity.

Interest Rate Risks

As of March 31, 2018, the Company’s total outstanding borrowings of $511.7 million consisted of $162.8 million of variable rate debt borrowings from a line of credit of $2.8 million denominated in Japanese Yen, borrowings under a term loan of $70.0 million under the Company’s Credit Facility denominated in U.S. dollars and a line of credit borrowing of $90.0 million under the Company’s Credit Facility denominated in U.S. dollars. As such, the Company is exposed to market risks arising from changes in interest rates. An increase in the interest rate of these borrowings of 1% would have resulted in additional interest expense of $0.4 and $1.5 million for the three and nine months ended March 31, 2018.

36

Item 4. | CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company’s management evaluated, with the participation of the Company’s President and Chief Executive Officer, and the Company’s Chief Financial Officer and Treasurer, the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q. The Company’s disclosure controls were designed to provide reasonable assurance that information required to be disclosed in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. It should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. However, the controls have been designed to provide reasonable assurance of achieving the controls’ stated goals. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

Changes in Internal Control over Financial Reporting

No changes in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) were implemented during the Company’s most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.

37

Part II – Other Information

Item 1. | LEGAL PROCEEDINGS

The Company and its subsidiaries are involved from time to time in various claims, lawsuits, and regulatory proceedings incidental to its business. The resolution of each of these matters is subject to various uncertainties, and it is possible that these matters may be resolved unfavorably to the Company. Management believes, after consulting with legal counsel, that the ultimate liabilities, if any, resulting from these legal and regulatory proceedings will not materially affect the Company’s financial condition, liquidity or results of operations.

Item 1A. | RISK FACTORS

In addition to the other information set forth in this Quarterly Report on Form 10-Q, carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended June 30, 2017 and Part II, “Item1A. Risk Factors” in our Quarterly report on Form 10-Q for the quarter ended December 31, 2017, which could materially affect our business, financial condition or future results. Those risk factors are not the only risks facing the Company. Additional risks and uncertainties not currently known or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results. Except as set forth below, we believe there have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K for the year ended June 30, 2017 and our Quarterly Report on Form 10-Q for the quarter ended December 31, 2017.

Changes in U.S. trade policies could impact the Company’s international operations and the cost of imported goods into the United States, which may materially impact our revenues or increase our operating costs.

On March 23, 2018, President Trump announced new steel and aluminum new tariffs, and on April 15, 2018, the U.S. Department of Commerce issued a denial order against two companies in the telecommunications market. Other international trade actions and initiatives also have been announced by the U.S., and other countries in which we do business. Further changes in U.S. trade policy, or additional sanctions, could result in retaliatory actions by other countries that could materially and negatively impact the volume of economic activity in the U.S. This, in turn, may decrease our access to customers and markets, reduce our revenues, and increase our operating costs. If those costs cannot be passed on to our customers, our business and profits may be materially and adversely affected.

Item 2. | ISSUER PURCHASES OF EQUITY SECURITIES

In August 2017, in conjunction with the Company’s offering and sale of the Notes, the Company’s Board of Directors authorized the Company to purchase up to $50 million of its Common Stock with a portion of the net proceeds received from the offering and sale of the Notes. The shares that were purchased by the Company pursuant to this authorization were retained as treasury stock and are available for general corporate purposes. The Company purchased 1,414,900 shares of its Common Stock for approximately $49.9 million pursuant to this authorization.

In August 2014, the Company’s Board of Directors authorized the Company to purchase up to $50 million of its Common Stock through a share repurchase program (the “Program”) that calls for shares to be purchased in the open market or in private transactions from time to time. The Program has no expiration and may be suspended or discontinued at any time. Shares purchased by the Company are retained as treasury stock and available for general corporate purposes. As of March 31, 2018, the Company has cumulatively purchased 1,316,587 shares of its Common Stock pursuant to the Program for approximately $19.0 million. The dollar value of shares that may yet be purchased under the Program is approximately $31.0 million.

The following table sets forth repurchases of our Common Stock during the quarter ended March 31, 2018:

|  |  |  |  |  |  |  |  |  |  | Total Number of |  |  | Dollar Value of |
|  |  |  |  |  |  |  |  |  |  | Shares Purchased |  |  | Shares That May |
|  |  |  |  |  |  |  |  |  |  | as Part of Publicly |  |  | Yet be Purchased |
|  | Total Number of |  |  |  | Average Price Paid |  |  | Announced Plans or |  |  | Under the Plan or |
Period |  | Shares Purchased |  |  |  | Per Share |  |  | Programs |  |  | Program |
January 1, 2018 to January 31, 2018 |  |  | - |  |  |  | $ | - |  |  |  | - |  |  | $ | 30,906,904 |
February 1, 2018 to February 28, 2018 |  |  | 1,097 |  | (1) |  | $ | 38.56 |  |  |  | - |  |  | $ | 30,906,904 |
March 1, 2018 to March 31, 2018 |  |  | 2,998 |  | (2) |  | $ | 38.25 |  |  |  | - |  |  | $ | 30,906,904 |
Total |  |  | 4,095 |  |  |  | $ | 38.33 |  |  |  | - |  |  |  |  |

(1) | Includes 1,097 shares of our Common Stock transferred to the Company from employees in satisfaction of minimum tax withholding obligations associated with the vesting of restricted stock awards.

(2) | Includes 2,998 shares of our Common Stock transferred to the Company from employees in satisfaction of minimum tax withholding obligations associated with the vesting of restricted stock awards.

38

Item 6. | EXHIBITS

Exhibit Number |  | Description of Exhibit |  | Reference
31.01 |  | Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, and Section 302 of the Sarbanes-Oxley Act of 2002 |  | Filed herewith.
31.02 |  | Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, and Section 302 of the Sarbanes-Oxley Act of 2002 |  | Filed herewith.
32.01 |  | Certification of the Chief Executive Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |  | Furnished herewith.
32.02 |  | Certification of the Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |  | Furnished herewith.
101 |  | Interactive Data File |  | Filed herewith.

The Registrant will furnish to the Commission upon request copies of any instruments not filed herewith that authorize the issuance of long-term obligations of the Registrant not in excess of 10% of the Registrants total assets on a consolidated basis.

39

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | II-VI INCORPORATED
|  | (Registrant)
Date: May 9, 2018 |  | By: | /s/ Vincent D. Mattera, Jr.
|  |  | Vincent D. Mattera, Jr
|  |  | President and Chief Executive Officer
Date: May 9, 2018 |  | By: | /s/ Mary Jane Raymond
|  |  | Mary Jane Raymond
|  |  | Chief Financial Officer and Treasurer

40